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Dear Cancer Partner:
We are pleased to present to you the Florida Cancer Plan and the accompanying, Florida 
Cancer Plan Guide: Building Blocks to Reduce the Burden (hereafter referred to as the 
“FCP Guide”). The Florida Cancer Plan was created through a joint effort between the 
Florida Cancer Control and Research Advisory Board, the Florida Cancer Plan Council,
and the Florida Department of Health. This Florida Cancer Plan builds on the strong
foundation provided by the Florida Cancer Plan 2003 - 2006.
Although Florida continues to have the second highest cancer burden in the country, we 
have made significant strides in reducing this burden for Floridians. The Florida Cancer
Plan is a culmination from a broad spectrum of expertise from across the state. It 
outlines our goals and defines strategies to further reduce the cancer burden.
We wish to thank the many Floridians, throughout the state, whose contributions and 
participation in cancer control activities have strengthened our fight against cancer and,
especially, those committed individuals who have given their time, resources, and effort
to help create and implement this cancer plan.
We invite you to learn more about cancer control activities in Florida and the role each 
one of us can play in helping win our battle against this disease.
Florida Department of Health	 Cancer Control and Florida Cancer Plan
Research Advisory Council Council
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Executive Summary
Florida is home to more than 19 million diverse, multi-cultural, and multi-lingual people 
for whom cancer is a personal issue. In fact, Florida ranks second in the nation in newly
diagnosed cancer cases and mirrors national trends for the top cancer sites. On average,
there are 100,000 new cancers diagnosed and reported annually to the statewide cancer
registry, the Florida Cancer Data System. Advancing age is the top risk factor for the 
development of cancer. Overall, approximately 60 percent of newly diagnosed cancers
and 70 percent of cancer deaths occur in persons age 65 and older. This age group 
accounts for approximately 18 percent of Florida's total population. However, cancer
occurrence in Florida differs not only by age, but also by sex, race, geography, and the 
stage of disease at diagnosis depending on the site of the cancer. Cancer is the second
leading cause of death with approximately 40,000 deaths annually in Florida. However, 
of the leading causes of death in Florida, cancer ranks first in terms of years of potential
life lost, surpassing heart disease and stroke and unintentional injuries. Moreover, cancer
constitutes an economic burden on Floridians with approximately $4 billion in hospital
charges for in-patient hospital care in which cancer is the primary diagnosis.
The Florida Cancer Plan was created through a collaborative effort with Florida’s cancer
stakeholders. The state’s current cancer control efforts are focused to build on the 
previous cancer plan’s successes and outlined to address future strategies to achieve the 
plan’s four goals. These goals include building partners, providing cancer prevention
education, ensuring accessibility, and improving quality of life for all Floridians.
The Florida Cancer Plan provides an overview of the cancer burden in Florida, health
disparities by population, specific behavioral and preventive measures that may reduce 
one’s risk of cancer, and early detection techniques by 10 specific cancer sites or 
classifications. These cancer sites and classifications include breast, cervical, childhood,
colorectal, lung, lymphoma, oral and pharyngeal, ovarian, prostate, and melanoma of 
the skin. These specific cancer sites have been included because they are either the most
common cancer sites or are some of the most receptive to prevention and early
detection. More importantly, when addressed through public health and policy, 
decreasing the incidence and mortality of these cancers can reduce the burden of cancer
in Florida and nationwide.
A network of dedicated individuals leads and implements these cancer efforts.  They 
volunteer hundreds of hours to the governor-appointed Florida Cancer Control and 
Research Advisory Council, the Florida Cancer Plan Council, and regional collaboratives.
In addition to the Florida Cancer Plan, the cancer stakeholders have developed a 
supplementary document, the Florida Cancer Plan Guide. It is a working document 
where cancer partners develop strategies toward achieving the cancer plan goals.
Please see Appendix D.
5
  
 
       
 
      
       
    
      
         
          
           
     
       
 
 
          
     
    
     
       
 
 
         
    
    
    
    
    
       
 
 
       
        
              
            
    
           
      
             
            
       
          
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
 
 
 
What You Can Do To Fight Cancer In Florida!
If you are a Floridian, you can:
• Quit smoking and avoid secondhand smoke
• Maintain a nutritious diet
• Be physically active each day
• Know when to be screened and get screened
• Consider enrolling in a clinical trial if you have cancer
• Get involved with your local cancer collaborative by contacting
 
the Florida Department of Health
 
• Support those living with cancer
If you are a community or Faith Based Organization, you can:
• Provide cancer prevention education
• Promote cancer screening
• Support cancer service providers
• Support those living with cancer
If you are an employer or a hospital, you can:
• Maintain a smoke-free environment
• Provide healthy foods
• Promote physical activity
• Promote cancer screening
• Provide health insurance
• Support those living with cancer
If you are a policy maker, you can:
• Promote systems changes that will increase cancer screenings
• Join the comprehensive cancer control efforts in Florida in a way that
directly contributes to the coordination and success of the movement at the 
state and collaborative level.1 
• Support policies that are effective and will lead to environmental and 
behavioral changes that impact cancer.2 
• Encourage constituents to join you in eliminating cancer by building awareness
and advocacy for cancer prevention, early detection, access to quality care,
eliminating disparities in health, and increasing survival.3 
• Support Florida initiatives regarding tobacco settlement and enforcement of
Clean Indoor Air Act.4 
1 C-Change, The Comprehensive Cancer Control Movement Ten Years of Success 1998 to 2008, p. 15-16.
2 Ibid
3 Ibid
4 Ibid
6
  
 
     
 
             
            
           
                
    
 
               
          
         
              
              
            
             
              
           
          
            
            
             
             
 
          
            
          
            
      
 
 
          
             
         
           
              
               
          
           
            
               
 
 
         
           
             
History Of Cancer Control In Florida
The State of Florida has had a cancer plan for almost 30 years. The first Florida Cancer
Plan was written and approved by the Florida Cancer Control and Research Advisory
Council (CCRAB) in 1981. The CCRAB was established by state statue in 1979 and 
mandates the approval of a state cancer plan. This process and the plan’s content has
evolved over the years.
The first cancer plan, and subsequent plans in the 1980s, called for the use of data to 
identify high risk groups and gaps in cancer services. The plans included 
recommendations to develop and evaluate interventions, which improve early detection 
and assess patient care. To fund these activities, the CCRAB sought state funding,
including the allocation of a proposed cigarette tax in 1986 to be used for cancer control
programs, but was unsuccessful in securing these funds. The 1990 Florida Cancer Plan
was the first to include detailed state and county level cancer incidence and mortality
data. It also linked Florida data to national goals set forth in the Healthy People 2000 
objectives. In 1993, the Florida Cancer Plan updated data from the 1990 plan and 
established four priorities: (1) lung cancer, (2) breast and cervical cancer, (3) access to 
preventive care and screening, and (4) statewide cancer control efforts.  In addition, the
plan included recommended emerging issues, which were to be explored in future
plans. These issues were prostate and colorectal cancer screening and skin cancer. These 
issues were addressed and goals were reported in the 1994 Florida Cancer Plan Update.
The 1998-1999 Florida Cancer Plan was prepared and approved by the CCRAB in 1997.
Its priorities were access to care and insurance issues, tobacco use among youth, access 
to breast and cervical cancer screening, and awareness about prostate cancer screening 
and treatment options. The emerging issues in this plan were colorectal cancer
screening, skin cancer, and genetic testing.
The last Florida Cancer Plan 2003-2006 was developed through a collaborative effort 
with the CCRAB and the Florida Department of Health Comprehensive Cancer Control 
(CCC) Program.  The Cancer Plan was approved by the CCRAB in 2003. It was developed 
to outline a strategic plan for statewide  comprehensive cancer control  efforts  and to 
provide cancer data by cancer site.  The Florida Cancer Plan 2003-2006 identified the 
state’s 12 priority goals, the strategies, and the proposed partners necessary to 
implement these initiatives. 
The Florida Cancer Plan Council (FCPC) was created through guidance by the Centers for 
Disease Control and Prevention (CDC) and other federal partners, at the 2004 national
Comprehensive Cancer Control Leadership Institute. The FCPC oversees the partners’
efforts toward accomplishing Florida Cancer Plan’s goals, provides technical assistance,
and supports the regional collaboratives. The FCPC membership voted to focus their
initial efforts on four of the 12 goals. These four goals were: (1) increase behaviors
associated with primary prevention among Floridians of all ages, (2) increase 
communication and collaboration among public and private cancer control stakeholders
statewide, (3) reduce factors that contribute to disparities in Florida’s cancer burden,
and (4) enhance the quality of life for Florida’s families and friends with cancer.
The FCPC members developed four affinity groups and conducted business through 
e-mails and conference calls. The affinity groups were successful in creating a FCPC
brochure to be used as a marketing tool, developing two online, cancer educational 7 
  
 
         
         
 
               
          
            
           
            
   
 
     
 
 
           
             
            
           
           
            
          
          
 
       
 
 
           
             
                
           
          
           
               
              
           
            
     
 
   
 
            
            
             
        
                
           
               
               
             
             
             
           
            
  
 8
modules for health professionals, strengthening cancer networks, and revising 
educational materials to be more culturally and linguistically appropriate.
For this current edition, the CCC Program and the FCPC consulted with an expert in
System Dynamics Modeling (please see Appendix A for further detail) to refine the 
cancer plan’s goals. This cancer plan was developed through a collaborative process
involving CCRAB and FCPC members and Florida cancer experts who provided the 
leadership, support, and guidance to implement the identified strategies in this year’s
Florida Cancer Plan.
FLORIDA CANCER PLAN COUNCIL (FCPC)
The FCPC is comprised of volunteer cancer stakeholders from across the state who 
coordinate cancer control efforts.  The FCPC has continued over the years to provide
leadership and direction. Some of the FCPC’S activities have included implementing the
Florida Cancer Plan, coordinating statewide cancer control efforts and contributing 
partners, assuring accountability, and supporting the regional collaboratives. The FCPC 
represents 25 areas across Florida that include the chairs of the regional cancer
collaboratives, the American Cancer Society, Cancer Information Services, cancer
hospitals, universities, the Susan G. Komen Foundation, and cancer survivors.
CANCER CONTROL RESEARCH AND ADVISORY COUNCIL (CCRAB)
The CCRAB is the legislatively mandated state council responsible for advising the 
legislature, the Governor, and the State Surgeon General to provide solutions and policy 
alternatives on how to reduce the cancer burden in Florida. The CCRAB monitors cancer
data, trends, and disparities and evaluates and promotes effective interventions to help 
in cancer prevention, screening, and treatment. Also, the CCRAB develops position 
papers on cancer-related legislation and state policy issues and is responsible for 
approving the state cancer plan. An annual report outlining the CCRAB’s activities is
submitted to the Governor and the State Surgeon General on February 15th of each year.  
For more information on the CCRAB, please visit www.ccrab.org. The 35 members of the
CCRAB are leaders in health care, education, cancer research and treatment, and Florida
government. Many are cancer survivors.
REGIONAL CANCER COLLABORATIVES
Due to Florida’s geographically large and diverse state, there is a need for more 
localized planning as well. In 2000, the U.S. Congress appropriated funds to develop 
comprehensive regional cancer control plans in Florida. Funding was awarded to the 
University of Miami, Sylvester Comprehensive Cancer Center through a cooperative 
agreement with the CDC as part of their CCC Program. This resulted in the Florida 
Comprehensive Cancer Control Initiative (FCCCI), which established four regional cancer
control collaboratives covering all 67 Florida counties (see map below). From 2000 to
2003, cancer control stakeholders in each of the four regions were invited to participate
in a strategic planning process. From this, four regional cancer control plans were 
developed. In addition to regional goals, objectives, and strategies, each plan included 
detailed county-level cancer and demographic data, as well as a directory of cancer
resources. The regional plans were integrated into the 2003-2006 Florida Cancer Plan,
and representatives from each regional collaborative continue to be active members of 
the FCPC.
9  
 
 
 REGIONAL CANCER CONTROL COLLABORATIVES 
AMERICAN CANCER SOCIETY 
The American Cancer Society is the nationwide, community-based  voluntary health 
organization dedicated to eliminating cancer as a major health problem  by preventing 
cancer, saving lives and diminishing suffering from cancer through research, education, 
advocacy and service. In Florida, the American Cancer Society is a leader in educating  the 
public about cancer prevention, early detection and treatment options, as well as 
providing patients critical services to help them triumph over cancer. It has led successful 
efforts  to utilize  public policy to decrease tobacco use, including providing leadership to 
help pass the state's clean indoor  air laws, guarantee  funding for tobacco prevention and 
education  and raise the state's tobacco tax by $1 per pack. The American Cancer Society 
also has been a leader in advocating  for state funding for cancer research, as well as 
supporting Florida institutions seeking research funding from the Society's nationwide 
research program. 
 
Northwest FL Collaborative http://www.nwfcc.net/ 
North Central FL Collaborativehttp://www.ncfcancercontrol.org/ 
Southeast FL Collaborative http://sfccc.med.miami.edu/ 
Southwest Collaborative http://www.swflccc.com/ 
Northwest Region:
Bay, Calhoun, Escambia, 
Franklin, Gadsden, Gulf, 
Holmes, Jackson, Jefferson, 
Leon, Liberty, Madison, 
Okaloosa, Santa Rosa, Taylor, 
Wakulla, Walton, Washington
Central Region:
Alachua, Bradford,
Columbia, Dixie, 
Gilchrist, Hamilton, 
Lafayette, Levy, 
Putnam, Sumter, 
Suwannee, Union
Southwest Region:
Charlotte, Citrus, 
Collier, DeSoto, Glades, 
Hardee, Hendry, 
Hernando, Highlands, 
Hillsborough, Lee, 
Manatee, Pasco, Pinellas, 
Polk, Sarasota
Northeast Region:
Baker, Brevard, Clay, 
Duval. Flagler, Lake. 
Marion, Nassau, 
Orange, Osceola, St. 
Johns, Seminole, 
Sumter, Volusia
Southeast Region:
Broward, Miami-Dade,
Indian River, Martin,
Monroe, Okeechobee,
Palm Beach, St. Lucie
  
 
 
 
 
 
         
 
          
         
           
        
          
             
             
           
 
 
   
 
 
             
               
            
          
              
              
             
            
             
             
                
            
              
               
              
             
            
            
           
            
 
 
 
      
        
        
        
   
The Structure of the Plan and Remarks on Its Use of Data
 
The Cancer Plan serves as a guide for healthcare professionals, policy makers, and 
community members to understand Florida's cancer incidence, mortality rate and 
screening rates, and to identify partnership opportunities in Florida’s cancer control
activities. The accompanying Florida Cancer Plan Guide provides stakeholders with 
general strategies to personalize their cancer plan, build coalitions, and effectively 
address Florida’s cancer needs. (See Appendix D for an abridged version of the Florida 
Cancer Plan Guide.) The strategies listed in this cancer plan are not prioritized, nor
considered a comprehensive list but may provide initial guidance for Florida cancer
stakeholders.
The Cancer Plan:
1) Defines the state's cancer burden 
2) Outlines the four major goals for cancer control 
3) Identifies  overarching  strategies as a crosscutting tool 
4) Identifies  cancer site specific strategies 
5) Provides a background on the various statewide  cancer partners 
Cancer remains the second leading cause of death for Floridians, after heart disease.
Cancer is not just one disease, nor can it be defined through any single dataset. For this 
reason, the Florida Cancer Plan includes a variety of data sources to provide a more
comprehensive understanding of cancer and to assess the appropriate interventions.
Incidence data are provided by the state cancer registry, the Florida Cancer Data System
(FCDS) for the period from 1981 through 2006. Mortality data are provided by the
Florida Department of Health Office of Vital Statistics for the most current available year
(2006 or 2007).  In addition, screening data are provided by the Florida Behavioral Risk
Factor Surveillance System (BRFSS), with the exception of when Florida data are 
compared to the national screening rates in which the source is the CDC BRFSS. The 
timeliness of the data depends on the data source. More specifically, in the FCDS there is
an approximate year to a year-and–a-half time lapse from when a cancer diagnosis is
reported by a physician to when the data is released. Each facility, laboratory, and
practitioner is required to report the data within six months of each diagnosis and within 
six months of the date of each treatment. Consequently, there is an inherent time lag 
between data collection by the registry and when cancer data are available for data 
analysis, dissemination, and surveillance activities. Data sources for this cancer plan 
include cancer incidence and mortality rates from Florida's cancer registry, the FCDS,
Florida’s BRFSS, Surveillance Epidemiology and End Results (SEER), Florida Community
Health Assessment Resource Tool Set (CHARTS), and the Office of Vital Statistics.
Cancer is the leading cause of
death for all people in the U.S. under
the age of 65 and the second leading
cause of death for people of all ages.
National Vital Statistics Reports
10
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Cancer In Florida...A Snapshot
Number of New Cancer Cases by Sex and Race, Florida 2006
All
Cancers
Lung & 
Bronchus Prostate Breast Colorectal
Oral & 
Pharyngeal
Cancer* Melanoma Ovary Cervix
†Florida 100,303 16,154 14,043 12,826 10,173 2,749 3,388 1,478 907
Female 46,787 7,306 12,826 4,939 841 1,342 1,478 907
Male 53,442 8,835 14,043 5,222 1,904 2,046
Black 8,888 1,153 1,704 1,226 986 211 117 159
White 88,506 14,755 11,837 11,203 8,914 2,470 3,388 1,315 719
Black
Female 4,162 405 1,226 530 78 117 159
White
Female 41,236 6,769 11,203 4,270 743 1,342 1,315 719
Black
Male 4,718 746 1,704 456 133
White
Male 41,216 7,976 11,837 4,633 1,725 2,046
Source of Data: Florida Cancer Data System
*Oral Cancer consists of the following sites: lip, tongue, salivary glands, boor of mouth, gum and other mouth, nasopharynx, tonsil, oropharynx,
 
hypopharynx, other buccal cavity, and pharynx.
 
†Florida incidence total counts and rates throughout this report include 1,140 new cancer cases in persons of "other" races, 882 cases with
unknown race, 44 cases with unknown or unspeci1ed sex, and 2 cases with unknown age. Totals by sex include cases with unknown age and race, 
as well as cases with “other” race. Totals by race include unknown sex and age.
During 2006, physicians diagnosed 100,303 new primary cancer cases among Floridians,
an average of 275 cases per day. Cancer occurs predominantly among older people, as
age is the top risk factor. Approximately 60 percent of the newly diagnosed cancers in
2006 occurred in persons age 65 and older; this age group accounts for 18 percent of
Florida’s population. The four most common cancers in Floridians were lung and 
bronchus (16,154 cases), prostate (14,043 cases), female breast (12,826 cases), and 
colorectal (10,173 cases), which accounted for 57 percent of all new cases in blacks and
53 percent in whites. Fifty-three percent of new cancers were diagnosed in males. The 
number of new cancer cases in Florida’s five most populous counties (Broward, Miami-
Dade, Hillsborough, Orange, and Palm Beach), which represent 42 percent of Florida's
population, accounted for 39 percent of the new cancer cases in Florida in 2006.
Over the 26-year period from 1981 to 2006, males had a higher incidence (age-adjusted 
incidence rate) than females. Among blacks, the incidence among males was between
55 percent and 102 percent higher than among females. Among whites, the incidence 
among males was between 28 percent and 53 percent higher than among females.
White females had higher age-adjusted incidence rates than black females in all 26 
years. The racial disparity varied between 10 percent and 27 percent. Black males had 
higher age-adjusted incidence rates than white males in all years, except in 1987, 1988,
and 2006.  The racial disparity between black and white males increased from 1989 until
1995; however, it has steadily declined since 1996.
Between 1981 and 2007,  advances in prevention, 
early detection, and treatment of cancer have 
decreased cancer death rates by nearly 18 percent. 
FCDS 
  
 
 
 
 
In 2006, the top sites for cancer deaths were lung and bronchus (11,795), colorectal 
(3,692), female breast (2,605), and prostate (2,079) .  In addition, deaths from cancers for 
which preventative health screening is available (breast, cervical, colorectal, and 
prostate cancers) accounted for 30 percent of all cancer deaths in blacks and 21 percent 
in whites. 
Over the 26-year period from 1981 to 2006, the age-adjusted mortality rates for all 
cancers combined decreased by 13 percent among females and 22 percent among males. 
Despite the greater decline in mortality for males in the past 26 years, the difference in 
mortality rates between  the sexes persists. In 2006, the rate for males was 47 percent 
greater than for females.  Moreover,  the age-adjusted mortality rates decreased 29 
percent among blacks and 16 percent among whites, between  1981 and 2006. 
Furthermore, the total  cancer mortality rates declined in all sex-race groups between 
1981 and 2006:  34 percent among black males, 20 percent among black females, 20 
percent among white  males, and 13 percent among white  females. 
          
 
  
 
   
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
           
                      
          
                      
           
                     
        
 
   
 
 
 
 
    
 
 
 
    
 
  
       
 
   
All 
Cancers
Lung & 
Bronchus Prostate Breast Colorectal Bladder Melanoma Ovary Cervix
†Florida 39,938 11,795 2,079 2,605 3,692 1,048 593 657 955 301
Female 18,281 4,996 2,605 1,804 290 181 188 955 301
Male 21,653 6,797 2,079 1,888 758 412 469
Black 3,725 906 325 340 399 59 54 72 56
White 35,731 10,774 1,735 2,223 3,249 974 531 657 876 240
Black 
Female 1,736 327 340 207 26 18 72 56
White 
Female 16,280 4,620 2,223 1,569 258 161 188 876 240
Black 
Male 1,988 578 325 192 33 36
White 
Male 19,448 6,153 1,735 1,680 716 370 469
 
 
 
 
   
     
Number Cancer Deaths Cases by Sex and Race, Florida 2006
12
Source of Data:  Florida Cancer Data System 
*Oral  Cancer consists of the following  sites:  lip, tongue, salivary glands, boor of mouth, gum and other mouth, nasopharynx, tonsil, oropharynx, 
hypopharynx, other buccal cavity, and pharynx. 
† Florida total counts include 265 deaths of persons of "other" races and 10 with  unknown  race; 4 deaths were recorded with  unknown  sex. Totals 
by sex include deaths with  unknown  and “other” races; totals  by race include deaths with  unknown  sex. 
During 2006, a total  of 39,938 Floridians died from cancer; an average of 110 deaths per 
day.  Cancer occurrence and death happens predominantly among older people as age is 
the top risk factor.  Approximately 72 percent of cancer deaths in 2006 were in persons 
age 65 and older.  Moreover,  males accounted for 54 percent of total  cancer deaths. 
Although 89 percent of cancer deaths were among whites, a greater percentage of 
blacks died from cancer at younger ages than did whites.  The percentage of cancer 
deaths in people under age 65 was 45 percent among blacks and 26 percent among 
whites. 
More information about the burden of cancer in Florida is provided  in the Florida 
Annual Cancer Report, an epidemiological series, available on the Florida Department of 
Health’s web site at www.doh.state.fl.us/disease_ctrl/epi/cancer/CancerIndex.htm or the
FCDS web site at www.fcds.med.miami.edu.
Oral & 
Pharyngea l Cancer*
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CANCER SCREENING DATA
The Behavioral Risk Factor Surveillance System (BRFSS) is an anonymous population-
based telephone surveillance system designed to collect data on health conditions,
behaviors, and emerging health issues. The BRFSS survey data have been widely used to 
monitor health behavior and health status at state and national levels.
Current Cancer Screening Practices,* Florida, 2008
Breast Cancer
Screening
Mammogram CBE
Cervical
Cancer
Screening
Pap
Colorectal
Cancer
Screening
FOBT C/S
Prostate 
Cancer
Screening
PSA DRE
Overall 65.8 66.2 66.2 21.0 56.2 75.6 53.9
Gender
Female 65.8 66.2 66.2 19.3 53.8
Male 23.0 59.1 75.6 53.9
Race/Ethnicity
NH White 66.2 68.3 68.3 21.8 58.8 79.4 57.0
NH Black 69.2 72.6 72.6 24.9 55.5 74.3 63.0
Hispanic 63.4 57.3 57.3 13.0 42.0 52.5 28.9
Source of Data: FL BRFSS
 
*Percentage of adults who had the recommended cancer screening:
 
NH - Non-Hispanic
 
Breast Cancer Screening
• Mammogram – Percentage of women 40 years of age and older who received 
a mammogram in the past year
• Clinical Breast Exam (CBE) – Percentage of women 18 years of age and older 
who had a CBE in the past year
Cervical Cancer Screening
• Pap Smear (Pap) – Percentage of women 18 years of age and older who 
received a Pap in the past year
Colorectal Cancer Screening
• Fecal Occult Blood stool Test (FOBT) – Percentage of adults 50 years of age and 
older who received a FOBT in the past year
• Colonoscopy or Sigmoidoscopy (C/S) – Percentage of adults 50 years of age and 
older who received a C/S in the past five years
Prostate Cancer Screening
• Prostate Specific Antigen (PSA) Test – Percentage of men 50 years of age and 
older who received a PSA test in the past two years
• Digital Rectal Exam (DRE) – Percentage of men 50 years of age and older who 
received a DRE in the past two years
  
 
 
 
 
 
 
 
 
    
 
 
            
           
             
            
    
 
 
      
 
 
 
  
 
SKIN CANCER BEHAVIORAL DATA
The need for information on sun protection and skin cancer prevention led to a 
collaborative effort between the Florida Department of Health, Bureau of Epidemiology
and Florida’s CCC Program. Two questions were developed and added to the 2005
Florida BRFSS to collect data on behaviors related to tanning. The same questions were 
included in the 2006 survey.
Tanning Practices and Product Use,* Florida, 2006
14
Practice/Product Use Percent 
Tan Enhancer 2.3 
Less than  SPF 15 6.0 
Greater than or equal to SPF 15 28.3 
Do not use any skin protection products 14.9 
Do not purposely tan 48.6 
Yes, re-apply 78.7
No, re-apply 21.3 
Source:   FL BRFSS 
*Approximately, 10,000 Floridians’ responses to the following question: 
When you are tanning, either outside or on an indoor tanning bed, what products do you 
usually apply to your skin?  For those who do purposely tan, do you reapply sun block? 
SPF = Sun protection factor 
  
 
 
   
 
   
 
 
            
            
    
 
            
               
             
             
             
 
 
           
      
 
          
       
 
         
          
 
 
            
           
 
              
             
            
       
 
               
           
          
 
 
 
 
 
 
 
 
 
 
 
 
 
    
     
 
  
    
Setting The Course
CANCER PLAN GOALS
The purpose of the Florida Cancer Plan is to outline the state’s goals, objectives, and 
strategies necessary to reduce the burden of cancer on individuals, families, and 
communities in Florida.
This Florida Cancer Plan was developed based on the tenets of the previous Florida
Cancer Plan 2006.  After an analysis of the previous plan and working with a consultant,
the FCPC, CCRAB, and the Florida Department of Health CCC Program revised the cancer
plan goals. The consensus among the members was for the previous cancer plan goals
to be redefined and simplified into four goals. These four goals are:
Goal One: A coordinated approach among public and private cancer control
stakeholders to implement cancer activities statewide.
Goal Two: Floridians practice the healthy behaviors associated with prevention 
of cancer or to reduction of risk.
Goal Three: Floridians have access to appropriate health information and 
effective health services for the timely detection, diagnosis, and treatment of 
cancer.
Goal Four: Floridians affected by cancer are aware of and have access to 
quality, appropriate services for quality of life, palliative care, and survivorship.
Each cancer site or classification has specific strategies that address each of the state’s
four goals. However, the FCPC and the CCRAB recognized that there are also 
overarching strategies applicable to each of the cancer sites. These strategies are 
categorically delineated and defined by programmatic components.
This Florida Cancer Plan is the first of two documents for cancer stakeholders to use in
assessing the cancer burden and planning cancer control initiatives. The cancer
stakeholders have developed a complementary document called the Florida Cancer Plan 
Guide.
“I do not want the word “cancer” to
define who I am. I am a wife, mother, 
sister, daughter, friend, and teacher. 
Those are the words that define me.”
Grizel Arencibia, cancer survivor. 15 
  
 
 
 
   
 
 
          
            
            
                
             
             
          
 
  
            
           
            
    
 
 
          
        
          
 
       
          
    
     
      
           
     
            
        
   
          
       
 
 
 
            
     
 
 
   
         
      
        
   
    
            
 
COMPONENTS AND OVERARCHING STRATEGIES
The cancer stakeholders who were instrumental in developing this cancer plan have 
identified 10 components that are overarching and affect each of the nine specific
cancer sites. Thus, each component and the applicable strategies are outlined below to 
ensure these areas will be addressed in cancer control activities. A brief definition of
each component is offered and has the strategies prioritized. These strategies will not
be repeated again for each particular cancer site; however, there are certain exceptions
especially pertinent for a particular type cancer that will be repeated.
I. INFRASTRUCTURE: CAPACITY
Building statewide capacity among individuals, groups, and organizations is essential for 
all aspects of cancer care.  This includes formal and informal procedures, organizational 
policies, and leaders who create associations which are essential for planning and
implementing successful cancer efforts.
Strategies
1. Form groups of stakeholders to address strategies based on data, interest, 
abilities, and resources in order to build momentum.
2. Promote increased awareness and use of reliable data sources in practice and 
planning.
3. Determine statewide capacity for screening and treatment.
4. Coordinate	 cancer stakeholders and resources to support cancer education,
screening, policy, and legislation.
5. Encourage open communication among stakeholders.
6. Secure funds for cancer control.
7. Mobilize and empower community partners to develop and support a 
coordinated approach for cancer control.
8. Integrate systems to provide linkage and support with information, resources,
and services for comprehensive cancer prevention, screening, diagnosis,
treatment and survivorship.
9. Use data to establish an infrastructure and build capacity.
10. Support programs that ensure a competent, standard-based, medical
workforce.
II. LIFESTYLE
Personal health is affected by the individual’s behaviors in daily life. These include 
habits, preferences, and personal choices.
Strategies
1. Reduce smoking use.
2. Promote smoke free policies for work and community settings.
3. Promote personal responsibility with health.
4. Promote healthy diet, weight, and physical activity behaviors.
5. Promote sun safe measures.
6. Educate on safe sex practices.
7. Use behavioral data to identify and implement appropriate cancer control
initiatives.
16
  
 
 
 
            
     
 
 
             
  
          
 
           
  
         
             
    
 
   
             
          
 
 
         
       
       
           
   
            
 
 
           
          
 
 
 
        
 
        
   
       
           
        
        
       
            
       
 
 
 
 
      
        
         
     
 
III. DISPARITIES
Disease incidence and mortality rates can be substantially different between racial,
ethnic, gender, and economic groups.
Strategies
1. Assess cancer and behavioral data to identify populations with disparate
cancer rates.
2. Ensure cancer educational materials are appropriate for the populations at
risk.
3. Increase cancer screening and participation in clinical trials for the populations
at risk.
4. Promote research that focuses on disparate populations to identify causes.
5. Use data to identify and implement appropriate cancer control initiatives to
address health disparity issues.
IV. ACCESS TO CARE
The ability for Floridians to access the appropriate healthcare resources is critical for
ensuring timely and effective care, and enhancing quality of life.
Strategies
1. Identify barriers including transportation, socio/cultural factors, and language 
that interfere with access to care.
2. Reduce barriers for cancer care and related services.
3. Coordinate	 care resources and improve linkages to ensure access to cancer
care for all populations.
4. Identify and promote cancer prevention and care services for all populations.
V. EDUCATION
Education is an essential component in promoting and maintaining healthy behaviors
which leads to more informed decisions, and strengthens the spectrum of healthcare 
disciplines.
Strategies
1. Increase opportunities for continuing medical education for health 
professionals.
2. Create and disseminate culturally and linguistically appropriate cancer
materials for Floridians.
3. Develop cancer-specific public awareness campaigns to promote education
and screening for the timely detection, diagnosis, and treatment of cancer.
4. Create and disseminate educational materials for policy makers.
5. Promote and support the implementation of research-tested interventions.
6. Provide information and resources for cancer caregivers.
7. Use data to promote and inform populations on cancer prevention, detection,
diagnosis, treatment, services, research, survivorship, and palliative care.
Approximately one third of the most
common cancers are due to lifestyles - poor
diet, obesity, and lack of physical activity.
American Institute of Cancer Research
17
  
 
 
 
          
                
 
 
 
         
    
       
            
         
     
          
     
        
      
 
 
            
            
      
 
 
          
   
       
        
           
         
         
 
         
        
        
       
           
  
         
 
   
           
           
           
          
 
 
            
  
        
          
 
 
VI. RESEARCH
Active seeking and collecting of knowledge through experimentation, data inquires,
studies, surveys, focus groups, and other modalities need to be used in all aspects of
care.
Strategies
1. Advocate for research advancements for	 priority cancers and assist with
accurate cancer data collection.
2. Promote integration of genomic advances into practice.
3. Raise awareness of genomics and its importance in various aspects of cancer.
4. Promote and support	 continued research into aspects of cancer prevention,
screening, risk reduction, care, and survivorship.
5. Raise awareness and acceptance of clinical trials as an option.
6. Increase enrollment into clinical trials.
7. Raise physician awareness on patient participation in clinical trials.
8. Use data to support research initiatives.
VII. SURVIVORSHIP
Once a person is diagnosed with cancer, the individual is considered a cancer survivor. 
Cancer survivors face unique physical, psychosocial, and economic issues of cancer, from
diagnosis until the end of life.
Strategies
1. Identify and promote cancer-survivor and palliative-care services for cancer
survivors and care givers.
2 	Increase cancer survivors' awareness of and access to comprehensive 
survivorship services, which address cancer survivors’ needs throughout the 
full spectrum of cancer care, from diagnosis to the end of life.
3. Disseminate information about resources and services for cancer survivors,
their families, friends, and caretakers using a variety of methods and 
technologies.
4. Promote expansion of successful patient navigation programs within Florida’s
healthcare systems as appropriate for specific survivor populations.
5. Promote and support	 organizational partnerships that decrease barriers to 
survivorship resources for minorities and underserved populations.
6. Use data to promote and inform populations on cancer survivorship and 
palliative care.
7. Improve record keeping systems for patients with cancer.
VIII. POLICY LEGISLATION
Federal, state, and local regulations, including statutes, bills, rules, administrative codes
and laws, shape policy. These policies include healthcare practices which may be 
allowed, enforced, provided forbidden, and enhanced through these vehicles. Making
changes to these regulations, at any level, is a complex process.
Strategies
1. Mobilize partners and advocacy groups to develop and implement policy and
environmental changes.
2. Provide education for legislation that enhances cancer control.
3. Link advocacy and legislative groups to address cancer plan goals.
18
  
 
 
 
          
      
          
         
 
  
           
            
 
 
         
           
          
          
    
 
  
          
         
          
  
 
 
          
 
           
         
         
 
 
 
        
       
     
    
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 19
4. Support policies that ensure health insurance coverage for cancer prevention,
screening, and treatment for all Floridians.
5. Support actions and policy for healthcare coverage for all Floridians.
6. Support policies that ensure quality core healthcare standards.
IX. ENVIRONMENTAL FACTORS
The external atmosphere a person is living in creates positive and negative factors in
one’s environment, that affect their personal health, including their risk for cancer.
Strategies
1. Encourage a multi-disciplinary approach in educating and raising awareness
on environmental risk factors in regards to cancer based on data
2. Provide information on environmental risk factors associated with cancer.
3. Support policies and procedures to reduce or eliminate environmental factors
associated with cancer.
X. PATIENT NAVIGATION
The process of assisting patients through the network of services to facilitate
communication, coordinate care with providers, and decrease barriers to care. There 
may be community navigators, acute care navigators, and survivor navigators in all 
cancer types.
Strategies
1. Provide support and resources for a cancer patient navigation system based on 
data.
2. Increase use of patient navigators in the acute and community settings.
3. Provide training opportunities for cancer caregivers and health professionals.
4. Compile a database of cancer resources to assist with care navigation.
The National Cancer Institute’s Division of Cancer
Control and Population Sciences funds over 900 
grants valued at almost $400 million including 
surveillance, epidemiology, health services,
behavioral science and cancer survivorship.
  
 
 
   
 
    
      
           
 
 
 
 
            
           
           
               
           
          
 
               
               
              
          
             
    
 
 
           
              
      
 
   
 
 
            
             
          
                 
           
           
            
    
 
             
          
            
             
           
             
              
   
 
          
           
 
             
 
             
 
Specific Cancer Sites
BREAST CANCER
October is Breast Cancer Awareness Month
Lifetime Risk of Developing Breast Cancer is 1 in 8 Women5 
OVERVIEW
Breast cancer is predominantly a disease affecting women. In fact, breast cancer is the 
most common cancer among women, excluding basal and squamous skin cancer in the 
United States. However, a small number of men also develop breast cancer. Breast
cancer is the second most common cause of cancer death in females, second only to lung 
cancer. However, among Black females in Florida, there is little difference between the 
lung cancer death rate and the breast cancer death rate.
Breast cancer, as with most cancers, is classified on its extent of spread in the body. 
Treatment is most successful when breast cancer is discovered early - in the localized
stage. Mammography is the single most effective method of early detection, since it can 
identify cancer several years before physical symptoms develop. Nevertheless, women
should know size, symmetry, and skin appearance of their breasts and report any
changes to their doctor.
The national breast cancer five-year survival rate is 98 percent for localized disease, 84 
percent for regional disease, and 27 percent for distant disease. In 2007, 2,599 women
in Florida died of breast cancer.6 
THOSE AT RISK
There are modifiable factors that can reduce a woman’s risk of getting breast cancer. 
Modifiable factors that a woman may be able to control include having a physically
active lifestyle, maintaining a healthy weight, and reducing alcohol consumption. Risk
increases with the amount of alcohol consumed. To reduce the risk of breast cancer, the 
American Cancer Society recommends 45 to 60 minutes of physical activity or exercise,
five or more days a week. The American Cancer Society also recommends maintaining a 
healthy weight throughout life by balancing food intake with physical activity and 
avoiding excessive weight gain.
Breast feeding a baby and having a first child before the age of 30 also decreases a 
woman’s risk of developing breast cancer. Postmenopausal women who take estrogen 
and progesterone hormone therapy have a higher risk of breast cancer. At this time, 
there appears to be few strong reasons to recommend long-term use of postmenopausal
hormone therapy. Women should discuss the risks and benefits of hormone
replacement therapy, including the possible impact on cancer risk, with their healthcare 
provider before starting therapy or if they have been on hormones for an extended 
period of time.
Non-modifiable factors include gender, age, family history, previous radiation treatment
to the chest area, previous breast cancer, race/ethnicity, breast tissue characteristics, and
5 Surveillance Epidemiology and End Results (SEER) Stat Breast Cancer Fact Sheet. Retrieved from
http://seer.cancer.gov/statfacts/html/breast.html.
6 Florida Community Health Assessment Resource Tool Set (CHARTS). Retrieved from
http://www.floridacharts.com/charts/DeathQuery.aspx.
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genetic factors. Being a woman is the main risk factor for developing breast cancer. 
The risk increases with age, with two-thirds of breast cancers occurring in woman over 
the age of 55.
While 70-80 percent of the women who get breast cancer do not have a family history, 
having a mother, sister, or daughter with breast cancer doubles a woman’s risk. Women 
with mutations in either the BRCA1 or the BRCA2 gene account for 5-10 percent of
breast cancers, and have up to an 80 percent chance of getting breast cancer during
their lifetimes. Often these women develop breast cancer at a younger age than those
without the gene mutation. These women are also at increased risk for developing 
ovarian cancer. Other gene mutations can also increase a woman’s risk of developing 
breast cancer, as well as some other types of cancer.
A woman with cancer in one breast has a 3- to 4-fold increased risk of developing a new
cancer in the other breast or in another part of the same breast. This is different from a 
recurrence (return) of the first cancer. Women with denser breast tissue (as seen on a 
mammogram) have more glandular tissue and less fatty tissue and have a higher risk of 
breast cancer.
Women diagnosed with certain benign breast conditions may have an increased risk of 
breast cancer. Women should communicate with their physicians and be aware of their
breast tissue type and if it puts them at increased risk for breast cancer.
CANCER BURDEN
Florida’s 2006 mortality rate for breast cancer of 20.5 deaths per 100,000 women is
currently slightly better than the national Healthy People 2010 target of 22.3 deaths per
100,000 women.7 Florida also met the Healthy People 2010 mammography target of 70
percent utilization among woman age 40 and over: in 2006, 78 percent of Florida 
women reported having had a mammogram within the last two years.
Uninsured women who have breast
cancer are about 2.5 times more  likely
to be diagnosed at Stage III or IV than 
privately insured women.
American Cancer Society
7 Florida Cancer Data System retrieved from http://fcds.med.miami.edu/. 21 
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Source of data: Florida Cancer Data System
While female breast cancer rates in Florida are slightly lower than national rates, the 
mortality rates are nearly identical.
Source of data: Florida Cancer Data System Source of data: CDC BRFSS Interactive website
The percentage of female breast cancer cases diagnosed at an early, more treatable stage,
in Florida has increased 25 percent in the past 20 years. Reported screening rates among 
Floridians are similar to screening rates reported nationally.
DISPARITIES
In Florida, over 95 percent of females diagnosed with breast cancer are age 40 or older. 
Breast cancer is more common in white females; however, the breast cancer mortality
rate is higher among black females. Age-adjusted mortality rates of breast cancer
decreased by 32 percent among white females and by 16 percent among black females
between 1981 and 2006, increasing this racial disparity. In 2006, the mortality rate
  
 
 
           
             
                
            
    
 
  
 
 
           
           
             
           
            
           
       
 
           
              
              
    
 
     
        
   
             
             
             
          
   
 
   
         
               
                
             
     
 
    
 
 
         
          
         
         
      
         
        
  
 
 
 
          
       
among blacks was 33 percent higher than among whites.8 Research suggests that some 
of the disparity is due to black females developing more aggressive tumor types and 
having different types of breast cancer than white females.9 More research needs to be
done to understand the racial disparities occurring in breast cancer mortality between 
white and black females.
BEHAVIORAL MEASURES
The main measured behavioral factor is the compliance with mammography
recommendations. Florida met the national standards of the Healthy People 2010
mammography target of 70 percent among woman age 40 and older and in 2006, 78
percent of Florida women age 40 and over reported having a mammogram within the 
last two years. Women should also be meeting or exceeding the American Cancer
Society’s recommendation for 45 to 60 minutes of physical activity five days a week and 
eating a diet rich in fruits and vegetables.
Women are encouraged to discuss screening recommendations with their doctors.
Based on history, risk factors, and any symptoms including the results of the clinical
breast exam, they will agree on an age for them to start screening mammography and 
their intervals for screening.
Guidelines for routine screening:
The United States Preventative Services Task Force (USPSTF) website 
http://www.ahrq.gov/clinic/uspstf/uspsbrca.htm, recommends biennial screening 
mammography for women aged 50 to 74 years and states that the decision to start
regular, biennial screening mammography before the age of 50 years should be an 
individual one and take patient context into account, including the patient's values
regarding specific benefits and harms. The USPSTF recommends against teaching 
breast self-examination (BSE).
The American Cancer Society, website 
http://www.cancer.org/docroot/PED/content/ped_2_3x_ACS_Cancer_Detection_Guideline 
s_36.asp, states that yearly mammograms are recommended starting at age 40 and 
continuing for as long as a woman is in good health. They state that women should 
know how their breasts normally look and feel and report any breast change promptly
to their health care provider.  They state that breast self-exam (BSE) is an option for 
women starting in their 20s.
FLORIDA BREAST CANCER STRATEGIES
1. Increase breast cancer screenings for women over age 50.
2. Increase outreach	 efforts to high-risk populations to educate women
about screening options and refer those for appropriate screening.
3. Increase access for women to quality, accredited mammography facilities with 
reasonable waiting time for obtaining service.
4. Educate about signs and symptoms and promote breast self-awareness.
5. Increase awareness of inflammatory breast cancer for healthcare providers
and women.
8 FCDS Florida Annual Cancer Report Epidemiological Series: 2006 Incidence and Mortality.
9 American Cancer Society retrieved from http://www.cancer.org. 23 
  
 
 
  
 
 
      
              
 
 
 
 
              
            
           
            
             
           
              
   
 
           
              
     
 
   
 
 
           
           
              
             
                
           
 
 
             
            
           
        
 
        
 
 
           
                 
            
 
               
            
              
           
   
 
 
 
 
             
 
           
  
CERVICAL CANCER
January is Cervical Cancer Awareness Month
Lifetime Risk of Developing Cancer of the Cervix Uteri is 1 in 145 Women10 
OVERVIEW
Cervical cancer is cancer of the lower part of the uterus that connects to the vagina. 
Cervical cancer is highly preventable and is caused by a virus called the human
papillomavirus, or HPV, which is spread through sexual contact. Abnormal cervical cells 
rarely cause symptoms, but detection of the earliest changes leading to cancer
development is possible through the use of Pap tests.  Periodic Pap test screening as
recommended by healthcare providers can prevent the majority of invasive cervical
cancers. When abnormal cells are found and treated early, cervical cancer can be 
prevented or cured.
The national cervical cancer five-year survival rate is 92 percent for localized disease, 58 
percent for regional disease, and 17 percent for distant disease. In 2007, 262 women in
Florida died of cervical cancer.11 
THOSE AT RISK
There are modifiable factors that can decrease a woman’s risk for cervical cancer. 
Women who are vaccinated against HPV prior to becoming sexually active can 
significantly lower their risk of cervical cancer. HPV infection is one of the major risk 
factors for developing cervical cancer. HPV is a group of more than 100 related viruses.
HPV is passed from one person to another during skin-to-skin contact. HPV can be 
spread during sex including vaginal intercourse, anal intercourse, and even during oral 
sex.
Women who smoke are about twice as likely as non-smokers to get cervical cancer. 
Women who get regular Pap tests decrease their risk of cervical cancer by catching 
abnormal cells before they advance to cancer. Maintaining a healthy weight and 
healthy lifestyle decreases one’s risk of cervical cancer.
Non-modifiable risk factors include family history and immunosuppression.
Human immunodeficiency virus (HIV), the virus that causes AIDS, damages the body's
immune system and seems to make women more at risk for HPV infections. This may be 
what increases the risk of cervical cancer in women with AIDS.
Poverty is a risk factor for cervical cancer. Many women with low incomes do not have 
readily available access to adequate healthcare services, including Pap tests. This means
they may not get screened or treated for pre-cancerous cervical disease. If a mother or 
sister had cervical cancer, a woman’s chances of developing the disease increase by two
to three times.
10 Surveillance Epidemiology and End Results (SEER) Stat Prostate Cancer Fact Sheet. Retrieved from
http://seer.cancer.gov/statfacts/html/prost.html.
11 Florida Community Health Assessment Resource Tool Set (CHARTS) retrieved from
http://www.floridacharts.com/charts/DeathQuery.aspx.24
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CANCER BURDEN 
While the disease is almost totally treatable or preventable with  routine screening, 
almost 300 women die each year in Florida from cervical cancer. 
Florida’s 2006 mortality rate for cervical cancer of 2.7 deaths per 100,000 is 35 percent 
above the Healthy People 2010 target  of 2.0 deaths per 100,000 women.12  
Source of data: Florida Cancer Data System 
While cervical cancer rates in Florida are higher than in the nation  as a whole, the 
mortality rates are nearly identical. 
Source of data: Florida Cancer Data System Source: CDC BRFSS Interactive  website 
In Florida, the percentage of cervical cancer cases diagnosed at an early, more treatable 
stage has increased slightly in the past 20 years. Reported screening rates are similar 
nationally and among Floridians. 
12 Florida Cancer Data System Retrieved from http://fcds.med.miami.edu/. 25 
  
 
 
 
 
 
              
          
 
 
             
               
      
 
        
     
 
  
 
 
               
            
          
              
            
 
             
               
            
        
 
 
   
            
               
    
 
            
              
                
           
         
 
    
 
 
       
             
      
     
          
           
 
 
 
 
 
 
 
      
DISPARITIES
Nearly twice as many black women die from cervical cancer as white women. Poverty, 
access to care, education, and insurance coverage may somewhat explain these 
disparities.
Black females had higher incidence rates than white females in all 26 years of reported 
data to the FCDS. In 2006, the rate of cervical cancer for black females was 26 percent
more than the rate among whites.
Age-adjusted cervical cancer mortality rates among blacks was 69 percent higher than 
that among whites in 2006.
BEHAVIORAL MEASURES
Presently, Florida does not meet the national Healthy People 2010 Pap test target of 90
percent of women aged 18 years and older receiving a screening Pap test within the 
preceding three years. According to Florida BRFSS 2008 data, 83 percent of Florida 
women reported having a Pap test within the last three years.13 All women aged 18
and older should be aware of the importance of Pap test screening.
The public needs to be aware and informed about the HPV vaccine. The most significant
behavioral step parents can take is to get their daughters vaccinated against HPV prior
to becoming sexually active. To learn more about the Advisory Committee on 
Immunization Practices (ACIP) recommendations and guidelines please visit
http://www.cdc.gov/vaccines/recs/default.htm.
PREVENTION AND EARLY DETECTION
Primary prevention is available through the HPV vaccine. Women who receive the HPV 
vaccine still need Pap tests. Regular Pap tests can find abnormal cervical cells when they
are most easily treatable.
Prevention and early detection are possible for cervical cancer. The primary method of
diagnosing cervical cancer is through Pap testing. A Pap test involves examining cells
taken from the cervix. Women should begin Pap tests by age 21 or within three years of
sexual activity and continue annually until a woman has three consecutive normal Pap 
tests.  Then a woman should receive a Pap test every three years.
FLORIDA CERVICAL CANCER STRATEGIES
1.	  Increase screening rates, especially in high-risk populations.
2.	  Educate on the availability of the HPV vaccine in accordance with the
Advisory Committee on Immunization Practices (ACIP).
3.	  Educate youth on safe sex practices.
4.	  Educate women on cervical cancer screening and provide access to effective 
health services for the timely detection, diagnosis, and treatment of cancer.
13 Source: CDC BRFSS Interactive website.26
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CHILDHOOD CANCER
September is Childhood Cancer Awareness Month
OVERVIEW
Cancer occurs less frequently in children than in adults. Children account for less than 
one percent of cancer diagnoses in Florida. Despite this relatively small percentage,
approximately 750 new cases of cancer are diagnosed in children in Florida each year
and cancer remains the leading cause of death by disease in children. The types of
cancers seen in children are also quite different than those seen in adults, with leukemia 
being most common, followed by brain tumors, lymphomas, and then embryonal
tumors. Melanoma is increasing in occurrence in children in Florida and nationally.
Cancer in children is usually treated at specialized centers of which there are 16 in
Florida. Because children with cancer are treated at a time of rapid physical,
psychological, and developmental growth, they are particularly susceptible to long-term
complications associated with cancer treatment.
Overall survival for childhood cancer has improved dramatically with current estimates
that 80 percent of children diagnosed with cancer will be cured of their disease.
THOSE AT RISK
The majority of childhood cancers are caused by non-modifiable risk factors such as
genetic predisposition. Prior exposure to radiation or chemotherapy can also result in
secondary malignancies. While lifestyle related risks of the individual are the main 
factors leading to cancers in adults, these factors have diminished significance in
childhood cancer.
Modifiable factors to decrease the risk of childhood cancers include limiting a child’s
exposure to UVA and UVB rays.
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CANCER BURDEN
Source of data: Florida Cancer Data System
The cancer rates of Florida’s children under age 20 are similar to the national rates.
The percentage of childhood cancers diagnosed at an early stage has increased 37 
percent since 1987.
Childhood Cancer, Florida 1987-2006
Percent diagnosed at an Early Stage
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Source of data: Florida Cancer Data System
DISPARITIES
In Florida, childhood cancers account for less than one percent of all cancers diagnosed
in the state. Childhood cancer is a diverse group of rare malignancies, in which the most
frequently diagnosed is acute lymphocytic leukemia (ALL) and tumors affecting the 
central nervous system. In early childhood, ages 0 to 4, many malignancies are a result
of developmental changes during gestation as compared to post-birth exposure effects
in the development of cancers for adolescents.
  
 
 
           
            
           
  
 
   
 
 
            
             
             
              
          
             
     
 
     
 
 
       
         
        
  
       
          
    
       
      
              
 
 
 
 
 
 
 
 
 
 
     
        
     
      
         
         
    
     
      
      
      
       
  
   
  
 
 
 
Overall, survival rates for most childhood cancers are consistently higher in white 
children than in black children. Moreover, the outcomes are disparate among age 
subpopulations. Specifically, adolescents tend to have a lower survival rate than their
younger counterparts.
PREVENTION AND EARLY DETECTION
There are no specific screening tests for most childhood cancers and the symptoms
associated with cancer may mimic many other more benign illnesses. However, parents
and primary care physicians should be aware of the warning signs of childhood cancer
which include: an unusual mass or swelling; unexplained paleness and/or loss of energy;
sudden tendency to bruise; persistent, localized pain, or limping; prolonged unexplained 
fever or illness; frequent headaches, often with vomiting; sudden eye or vision changes;
and excessive, rapid weight loss.
FLORIDA CHILDHOOD CANCER STRATEGIES
1. Ensure access and support to comprehensive, multidisciplinary, age 
appropriate cancer care for children and adolescents with cancer.
2. Foster support of long-term follow-up services for children, adolescents, and 
young adults.
3. Require that primary care physicians and health professionals have 
appropriate education in the late effects of cancer treatment and appropriate 
screening for these effects.
4. Assure appropriate palliative care (expertise in symptom management) and 
end-of-life services for children in Florida.
5. Identify resources to offer support to siblings of children with cancer.
While dramatic improvements in survival
have been achieved for cancer patients at
age 15 or younger, and steady 
improvement has been made against
many cancers among adults over age 40,
little or no progress has been seen in the
adolescent and young adult population. In
fact, among those aged 25 to 35, survival
has not improved in more  than two
decades, and survival trends show a worse 
prognosis for young adults diagnosed
with cancer today than 25 years ago.
American Cancer Society, 
Lance Armstrong Foundation, National 
Cancer Institute
29
  
 
 
  
 
 
      
             
 
 
 
 
              
                 
                 
             
          
           
          
 
            
              
              
           
            
      
 
           
             
     
 
   
 
 
            
            
            
           
           
          
            
            
      
 
               
           
         
           
 
 
 
 
 
 
 
 
 
 
             
 
           
  
COLORECTAL CANCER
March is Colorectal Cancer Awareness Month
Lifetime Risk of Developing Colorectal Cancer is 1 in 19 for Women  and Men14 
OVERVIEW
Colorectal cancer is a cancer affecting the large bowel or lower digestive tract. It can 
develop along any point in the lining of the large intestine or rectum. Colorectal cancer
is the third most common type of cancer and the second most common cause of cancer
death for both males and females combined, second only to lung cancer. The disease is
largely preventable for the majority of the population through a variety of screening 
programs aimed at detecting pre-malignant growths (also called polyps) in the intestine 
and removing them prior to the development of the cancer.
Early detection of the cancer is critically important, as survival is nearly 90 percent when 
colorectal cancer is removed before it has spread beyond the intestinal wall. Individuals
may be completely unaware of the presence of disease until more advanced stages
when survival from the cancer drops considerably. Despite recent advancements in the 
treatment of this disease, prevention and early detection remain the best ways to 
combat this common and lethal condition.
The national colorectal cancer five-year survival rate is 91 percent for localized disease,
70 percent for regional disease, 11 percent for distant disease. In 2007, 3,710 people in
Florida died of colorectal cancer.15 
THOSE AT RISK
There are modifiable factors that will decrease a person’s risk of getting colon cancer. 
People who maintain a healthy low-fat diet low in processed and red meats, maintain 
an appropriate weight, and exercise regularly significantly decrease their risk of
colorectal cancer. Decreasing alcohol consumption lowers a person’s risk as well. People 
with type 2 diabetes and smokers have a higher mortality rate from colorectal cancer. 
There are non-modifiable factors that increase a person’s risk of colorectal cancer. These 
factors include being over age 50, having had polyps or colorectal cancer before, having 
a history of ulcerative colitis or Crohn’s disease, having a family history of colorectal
cancer, or having certain family syndromes.
Colorectal cancer affects men and women equally and is seen in all races and ethnicities,
but race and ethnicity can affect a person’s risk of developing the disease. African 
Americans and Jews of Eastern European descent (Ashkenazi Jews) have a higher 
colorectal cancer risk. The reasons for this are not yet understood.
14 Surveillance Epidemiology and End Results (SEER) Stat Colorectal Cancer Fact Sheet. Retrieved from
http://seer.cancer.gov/statfacts/html/colorect.html.
15 Florida Community Health Assessment Resource Tool Set (CHARTS). Retrieved from
http://www.floridacharts.com/charts/DeathQuery.aspx. 30
  
 
   
                 
               
 
 
 
 
 
 
 
 
      
  
    
 
  
    
Colorectal Cancer Screening
FOBT - Adults aged 50+ who have had a blood stool test within the past two years
Sigmoidoscopy - Adults aged 50+ who have ever had a sigmoidoscopy or colonoscopy
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CANCER BURDEN 
Colorectal cancer incidence and mortality rates in Florida and the nation  are similar. 
Source of data: Florida Cancer Data System 
 
Source: CDC BRFSS Interactive  website 
Source: CDC BRFSS Interactive  website  
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The percentage of colorectal cancer cases diagnosed at an early, more treatable stage in
Florida has increased 13 percent in the past 20 years (33 percent in 1987 versus 37 
percent in 2006).16  Fifty percent of patients in Florida were diagnosed at an advanced 
stage.
DISPARITIES
Over the 26-year period since 1981, incidence rates increased among blacks by 19 
percent in females and 2 percent in males.  Incidence rates for whites declined by 31 
percent in females and by 33 percent in males in the same period.
Mortality rates for both black females and black males were higher than for their white 
counterparts by 41 percent and 31 percent, respectively.17 
BEHAVIORAL MEASURES
The Florida BRFSS data shows that overall, 56 percent of Floridians age 50 and older 
received a colonoscopy or sigmoidoscopy in the past five years, and 30 percent received 
a FOBT in the past two years.
PREVENTION AND EARLY DETECTION
Primary prevention may be possible by maintaining a healthy lifestyle, a diet high in
fruits and vegetables and low in red and processed meats, and maintaining a healthy
weight throughout life.
Prevention and early detection is also possible though a variety of screening techniques.
The USPSTF strongly recommends that clinicians screen men and women 50 years of age 
and older for colorectal cancer. The goal of screening is to identify cancer at an early, 
pre-cancerous stage (called a polyp) and remove it completely, leading to a lower
incidence of cancer and improved survival.
A variety of screening tests, as recommended by the American Cancer Society and other
national organizations, are available to accomplish this goal. Screening testing involves 
evaluating the colon or stool for trace amounts of blood leaked from the cancer or 
polyp, through radiographic evaluation (air contrast double barium enema), or through 
direct visualization with a flexible sigmoidoscopy or colonoscopy. These tests should be 
repeated throughout an individual’s lifetime.
A person at higher risk for cancer based on family history or previous cancer may need 
to be screened more often or prior to age 50, or both.
FLORIDA COLORECTAL CANCER STRATEGIES
1. Increase the percentage of Floridians over the age of 50 screened for 
colorectal cancer.
2. Educate the population on colorectal cancer screening and provide access to
effective health services for the timely detection, diagnosis, and treatment of 
cancer.
3. Promote healthy lifestyle practices including avoiding tobacco use,
increasing physical activity and fruit and vegetable consumption.
16 Florida Cancer Data System Retrieved from http://fcds.med.miami.edu/.
17 Florida Cancer Data System Retrieved from http://fcds.med.miami.edu/.32
  
 
 
    
 
 
      
             
 
 
 
 
              
              
          
 
                
             
              
             
           
 
           
             
         
 
   
 
 
             
             
               
              
        
 
            
            
              
             
 
            
           
              
              
                
           
             
              
          
 
 
 
 
 
             
 
           
 
       
           
     
LUNG AND BRONCHUS CANCER
November is Lung Cancer Awareness Month
Lifetime Risk of Developing Lung Cancer is 1 in 14 for Women  and Men18 
OVERVIEW
Lung and bronchus cancer is the leading cause of cancer death for both men and 
women and is one of the most preventable cancers. Lung and bronchus cancer claims
more lives each year than colon, prostate, and breast cancers combined.
Cancer that begins in the lungs can be divided into two major types: small cell lung 
cancer and non-small cell lung cancer. Non-small cell lung cancer is more common than 
small cell lung cancer and usually grows and spreads more slowly. Small cell lung cancer
(also known as oat cell cancer) is less common, grows more quickly than non-small cell 
lung cancer, and is more likely to spread to other organs.
The national lung and bronchus cancer five-year survival rate is 53 percent for localized 
disease, 24 percent for regional disease, and 4 percent for distant disease. In 2007,
11,650 people in Florida died of lung and bronchus cancer.19 
THOSE AT RISK
There are modifiable risk factors that can significantly decrease a person’s risk of getting
lung and bronchus cancer. The CDC reports that in the United States about 90 percent
of lung cancer deaths in men and almost 80 percent of lung cancer deaths in women are 
due to cigarette smoking. Other factors that contribute to lung cancer risk include cigar 
and pipe smoking and environmental (“secondhand”) tobacco smoke.
Secondhand smoke, smoke from other people's cigarettes, is also harmful to non­
smokers. The smoke contains more than 4,000 chemical agents, at least 250 are known
to be harmful, and 50 of these are known to cause cancer.20  Every year, about 3,000 
nonsmokers in the United States die from lung cancer due to secondhand smoke.21 
A small percentage of lung and bronchus cancers are caused by non-modifiable risk 
factors including exposure to radon, pollution, having other lung diseases, and
race/ethnicity. The lung and bronchus cancer risk of a person who has smoked one pack
of cigarettes per day for at least 15 years is approximately 10 percent, with this risk 
higher in black men and lower in white women. The risk of lung and bronchus cancer
also appears to have a genetic component since persons with a first-degree family
relative with lung and bronchus cancer (parents, siblings, or children) may have twice 
the lung and bronchus cancer risk of those without a family history of the disease. CDC 
research has shown that on average, smokers die 13 to 14 years earlier than
non-smokers.
18 Surveillance Epidemiology and End Results (SEER) Stat Lung Cancer Fact Sheet. Retrieved from
http://seer.cancer.gov/statfacts/html/lungb.html.
19 Florida Community Health Assessment Resource Tool Set (CHARTS). Retrieved from
http://www.floridacharts.com/charts/DeathQuery.aspx.
20 National Cancer Institute. Retrieved from http://www.cancer.gov/cancertopics/factsheet/Tobacco/ET
Environmental Protection Agency “Setting the Record Straight: Secondhand Smoke is a Preventable Health
Risk” 21 Retrieved from http://www.epa.gov/smokefree/pubs/strsfs.html. 33
 
 
 
 
 
 
 
                   
 
 
 
 
 
 
    
      
Lung Cancer, Florida 1987-2006
Percent diagnosed at an Early Stage
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CANCER BURDEN
The FCDS reports there were 16,154 new lung and bronchus cancers diagnosed in 2006.
34
Lung Cancer, 1987 - 2006
Rates per 100,000
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Source of data: Florida Cancer Data System 
Source of data: Florida Cancer Data System Source: CDC BRFSS Interactive  website 
The percentage of lung and bronchus cancer diagnosed at an early, more treatable, stage 
is low at approximately 19 percent.
Florida’s 2006 mortality rate for lung and bronchus cancers of 48.3 deaths per 100,000 
persons is 8 percent above the national Healthy People 2010 target of 44.9.
Adults who are exposed to secondhand 
smoke at home or at work  increase their risk 
of developing lung cancer by 20% to 30%. 
CDC 
  
 
 
 
 
 
              
             
         
 
           
     
 
            
               
     
 
  
 
 
           
              
              
     
 
 
           
             
             
           
 
   
 
 
             
               
            
 
              
              
             
               
 
          
 
     
 
 
      
      
     
         
    
     
 
 
 
 
       
      
      
   
DISPARITIES
Incidence rates of cancer of the lung and bronchus are higher among males than among 
females. Incidence rates have decreased among males, and have increased 59 percent in
white females, and 55 percent in black females since 1981.
Black males have higher age-adjusted mortality rates of cancers of the lung and 
bronchus than white males.
White females have had higher age-adjusted mortality rates than black females since
1981. Mortality rates increased among both black and white females by 24 percent and
37 percent, respectively, from 1981 to 2006.22 
BEHAVIORAL MEASURES
Although smoking rates have decreased 18 percent since 1987, Florida’s current smoking
rate of 17.5 percent as of 2008, does not meet the Healthy People 2010 target of
tobacco use by 12 percent or less of adults.23   Exposure to secondhand smoke in Florida
households is estimated at 13 percent.
Among Florida’s youth, in 2009, 5.4 percent of middle school students and 14.3 percent
of high school students smoked at least once during the past 30 days (current cigarette 
use). Since 1998, the prevalence of current cigarette smoking has decreased by 70.8
percent among middle school students and 47.8 percent among high school students.24 
PREVENTION AND EARLY DETECTION
Primary prevention is possible to prevent the majority of lung and bronchus cancer
cases. The best way to prevent lung and bronchus cancer is to not use tobacco products,
to quit if you already do, and to avoid people who smoke.
Smoking cessation has immediate health benefits for both men and women of all ages.
The earlier one quits, the better the health benefit. According to the American Cancer
Society, research has shown that people who quit before age 50 reduce their risk of
dying in the next 15 years by half compared with those who continue to smoke.
There is no recommended early detection screening tests for lung cancer.
FLORIDA LUNG AND BRONCHUS CANCER STRATEGIES
1.  Eliminate or reduce adult tobacco use.
2.  Eliminate or reduce youth tobacco use.
3.  Reduce exposure to secondhand smoke.
4.  Support policies that reduce use and exposure to tobacco.
5.  Support research to find treatment.
6.  Increase participation in clinical trials.
22 Florida Cancer Data System Retrieved from http://fcds.med.miami.edu/.
23 FL BRFSS 2008 Survey Retrieved from http://www.doh.state.fl.us/disease_ctrl/epi/brfss/index.htm.
24 Florida Youth Tobacco Survey Retrieved from
http://www.doh.state.fl.us/disease_ctrl/epi/Chronic_Disease/FYTS/Intro.htm. 35
 
 
 
 
   
 
 
      
               
 
 
 
 
              
             
              
              
          
             
             
              
         
 
             
           
            
 
   
 
 
 
            
               
            
     
 
  
 
 
              
           
             
                
              
        
 
 
 
 
 
 
              
   
           
 
MELANOMA OF THE SKIN
May is Skin Cancer Awareness Month
Lifetime Risk of Developing Melanoma of the Skin is 1 in 53 for Women  and Men25 
OVERVIEW
Skin cancer is the most common cancer in the United States. Nearly all skin cancers are 
preventable by limiting unprotected exposure to the sun. When skin cancers occur, most
can be treated successfully if detected early – even melanoma, the most serious type of
skin cancer. Skin cancers are divided into two major categories: melanoma and non-
melanoma skin cancers. Non-melanoma skin cancers, such as basal and squamous cell 
carcinomas, are much more common. However, because it is not a requirement to
report non-melanoma skin cancers to central cancer registries, the exact number of
these skin cancers is unknown. Nationally, it is estimated that there are more than 1 
million cases of basal and squamous cell cancers per year.
The national five-year survival rate for melanoma of the skin when detected at a
localized stage is 98 percent, 62 percent for regional stage, and 15 percent for 
advanced/distant stage. In 2007, 693 people in Florida died of skin cancer.26 
THOSE AT RISK
There are modifiable risk factors that people control  to reduce their risk of skin cancer. 
Adults and children should avoid unprotected exposure to sun between  10 a.m. and 4 
p.m. even on cloudy days. Wear a hat, lightweight clothing, and sun glasses when in the 
sun. Apply and reapply a sun screen that is above SPF 15 and protects against UVA and 
UVB radiation. Do not use artificial tanning devices such as tanning beds. Excessive 
exposure to ultraviolet (UV) radiation in the form of sunlight  or tanning booths is a 
major risk factor for both melanoma and non-melanoma skin cancers. 
 Non-modifiable risk factors include having light skin color, a personal or family history 
of melanoma, the presence of moles and freckles, and infection with certain HPV. Risk
factors for basal and squamous cell cancers also include a personal or family history of
skin cancer and light-skin color.
CANCER BURDEN
In the United States, an estimated 62,480 new cases of melanoma will be diagnosed in
2008, and an estimated 8,420 people will die from this disease (these numbers exclude 
basal cell, squamous cell, and other skin cancers). Florida has the second largest number
of cases of melanoma in the country with an estimated 4,430 cases in 2008. While non-
melanoma skin cancer rates increase with age for both men and women under age 40,
melanoma is the second most common cancer type.
25 Surveillance Epidemiology and End Results (SEER) Stat Melanoma of the Skin Cancer Fact Sheet.
Retrieved from http://seer.cancer.gov/statfacts/html/melan.html.
26 Florida Community Health Assessment Resource Tool Set (CHARTS). Retrieved from
http://www.floridacharts.com/charts/DeathQuery.aspx.
36
  
 
 
   
   
 
 
 
 
 
 
    
           
Melanoma, 1987 - 2006
Rates per 100,000
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In 2006, 3,388 Floridians were diagnosed with  melanoma, and there were 657 deaths 
from this cancer. The age-adjusted incidence rate was 17.6 per 100,000 persons, 
compared to 19.8 for the United States (2006 data).  The age-adjusted mortality rate for
Florida was 3.1, compared to 2.7 for the United States. 
 
Melanoma  of the skin has been the cancer with  the greatest occurrence increase over 
the past 20 years both nationally and in Florida. 
Source of data: Florida Cancer Data System 
DISPARITIES 
The incidence and mortality rates are higher among white  males than white  females. 
Age-adjusted  incidence rates have increased by 64 percent among white  males and by 
30 percent among white  females since 1981.  The disparity between  sexes increased 
from 24 percent in 1981 to 56 percent in 2006.  Over the time period from 1981 to 2006, 
mortality rates increased by 29 percent for white  males, while the rates decreased by 15 
percent for white  females.  White males had higher mortality rates than white  females 
in all years. The rate for white  males was 95 percent higher than the rate among 
females in 1981, and 188 percent higher in 2006. 
BEHAVIORAL MEASURES 
The two main measured behavioral  factors to reduce the risk for melanoma of the skin 
is to limit  one’s exposure to the sun and to apply and reapply a sun screen that is above 
SPF 15 and protects against UVA and UVB radiation. According to the approximately 
10,000 Floridians who responded to the skin cancer questions on the Florida BRFSS, 
almost 21 percent reported that they either did not use any sun protection products or 
else used an inadequate protection strength  product,  almost half reported that they do 
not purposely tan.  Furthermore, a strong majority of them reported that they do 
reapply sunscreen. 
37
  
 
 
   
 
 
             
             
              
             
             
   
 
            
             
            
               
               
             
               
             
             
  
 
           
            
         
 
     
 
 
            
 
       
   
              
   
 
       
       
             
           
            
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREVENTION AND EARLY DETECTION
Primary prevention is possible to reduce a person’s risk of skin cancer. The incidence of
skin cancer can be reduced by reducing exposure to the main risk factor, UV radiation 
from sun exposure. Preventive measures, such as avoiding peak daytime sun exposure,
avoiding use of indoor UV tanning salons, seeking shade while outdoors, wearing sun 
protective clothing, and using sunscreen with SPF 15 or higher, are effective ways to 
prevent skin cancer.
Early detection may be accomplished through a visit to a healthcare provider in an office 
setting or through an organized screening program, and by recognition of potentially
dangerous skin lesions by patients and/or family members. The most common sign of
skin cancer is a change in the skin. In general, melanoma is observed using the ABCDE 
principles: A) asymmetric; B) irregular borders; C) a variety of colors or very dark in
color; D) a diameter greater than 6 mm (the size of a pencil eraser), and E) evolving or 
enlarging size or shape. Not all melanomas fit all these criteria, however, and not all
skin lesions that do fit the ABCDE criteria are actually cancerous. Still, these are valuable 
principles to keep in mind and any suspicious skin lesions should be evaluated and, if 
necessary, biopsied.
Early detection not only improves survival, but also reduces costs and disability, as care 
for advanced and terminal diseases accounts for the majority of healthcare costs and 
most of the side effects associated with melanoma treatment.
FLORIDA MELANOMA OF THE SKIN STRATEGIES
1. Promote	 “sun wise” school policies for students, teachers, and staff in Florida’s
schools.
2. Promote	 implementation of research-tested interventions to promote sun 
awareness in public schools.
3. Restrict the use of tanning beds to those over age 18 and ensure that current
regulations are enforced.
The  United States Preventative Services Task Force (USPSTF) website 
http://www.ahrq.gov/clinic/uspstf/uspsskca.htm, concludes that the current evidence is
insufficient to assess the balance of benefits and harms of using a whole-body skin
examination by a primary care clinician or patient skin self-examination for the early
detection of cutaneous melanoma, basal cell cancer, or squamous cell skin cancer in the 
adult general population.
38
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ORAL CANCER 
Oral Cancer Awareness Week is in April 
Lifetime Risk of Developing Oral Cancer is 1 in 98 for  Women and Men27  
OVERVIEW 
Oral and Pharyngeal Cancer (OPC) is the sixth most common cancer worldwide and the 
fifth leading cause of cancer deaths in Florida. 
Currently, only 60 percent of the people that are diagnosed with  OPC will survive five 
years or more.  Early detection of OPC is vital.  The majority of OPC is preceded by the 
patient having premalignant lesions.  The national OPC five-year survival rate is 83 
percent for localized disease, 54 percent for regional  disease, and 32 percent for distant 
disease. In Florida, 2,749 cases of OPC were diagnosed in 2007, with  approximately 691 
deaths.28  
THOSE AT RISK 
Source: CDC BRFSS Interactive  website 
While rates of oral cancers in Florida are slightly higher than in the nation  as a whole, 
the mortality rates are similar. 
The percentage of oral cancers diagnosed at an early, more treatable stage has 
remained low at 31 percent.  Florida does not meet the Healthy People 2010 target  of 
50 percent of oral cancers diagnosed in an early stage. 
A diet low  in fruits and vegetables is associated 
with  an increased risk of developing either  oral 
or colorectal cancer. 
American Cancer Society 
27 Surveillance Epidemiology and End Results  (SEER) Stat Oral Cancer Fact Sheet. Retrieved from 
http://seer.cancer.gov/statfacts/html/oralcav.html. 
28 Florida Community  Health Assessment Resource Tool Set (CHARTS). Retrieved from 
http://www.floridacharts.com/charts/DeathQuery.aspx.  39
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Oral Cancers, 1987 - 2006
Rates per 100,000
50
40
30
20
10
0
Florida Incidence Florida Mortality
United States SEER incidence United States Mortality
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
African American men have  the 
highest risk of developing oral cancer 
compared to any other  group  in the 
US population. 
(National Institute of Dental 
and Craniofacial Research) 
Males have higher mortality rates than females.  F ive-year relative survival is 
substantially  higher in whites than in blacks, and is particularly low in black males. 
Moreover,  the disparity in relative survival is apparent  across virtually all stages, ages, 
and anatomical  sites. 
CANCER BURDEN 
Source of data: Florida Cancer Data System 
DISPARITIES 
Males of both races have age-adjusted incidence rates two to six times the rates among 
females.  From 1987-2006, rates declined 53 percent among black males and 22 percent 
among black females.  Among males, blacks showed a decline by 53 percent while 
whites showed an increase by 3 percent. 
BEHAVIORAL MEASURES 
Florida’s 2006 mortality rate for oral cancers of 2.5 deaths per 100,000 persons meets the 
Healthy People 2010 target  of 2.7.  In 2004, Florida also met the Healthy People 2010 
screening target  of 20 percent of adult Floridians over the age of 40 reporting receiving 
an oral cancer screening exam by their dentist.  However, Florida does not meet the 
Healthy People 2010 target  of 50 percent of oral cancers diagnosed in an early stage. 
  
 
 
 
 
   
           
            
          
              
              
       
 
           
 
 
 
 
    
 
 
        
      
           
      
       
            
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREVENTION AND EARLY DETECTION
Primary prevention is possible to reduce a person’s risk of OPC. Primary prevention 
measures include not smoking or using any tobacco products and decreasing alcohol
consumption. Approximately 75 percent of patients diagnosed with OPC are tobacco 
smokers or chewers or are excessive alcohol users or all. Women receiving the HPV
vaccination will be at reduced risk of HPV related OPC. HPV may also contribute to 
approximately 20 percent to 30 percent of OPC cases.
Early detection and screening are possible through regular dental or physical exams, or 
both.
FLORIDA ORAL CANCER STRATEGIES
1. Raise awareness and increase training of dentists, physicians, and allied 
health professionals in effective OPC screening.
2. Support tobacco control	 efforts, especially smokeless tobacco use, and its
impact on the development of OPC.
3. Increase OPC screening by trained health professionals.
4. Support efforts	 to ensure health plan coverage of oral screening exams for 
adults.
5. Educate on HPV and its relationship with OPC.
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OVARIAN CANCER
September is Ovarian Cancer Awareness Month
Lifetime Risk of Developing Ovarian Cancer is 1 in 71 Women29 
OVERVIEW
Ovarian cancer is a malignancy, that begins in one or both ovaries. The most common
form of ovarian cancer is epithelial ovarian carcinomas, which account for 85 percent to
90 percent of all ovarian cancer cases. Stromal cell tumors are the next most common, 
accounting for five to seven percent of ovarian cancers. Over half of stromal tumors are
found in women older than 50, but about five percent of stromal tumors occur in girls.
The national ovarian cancer five-year survival rate for is 94 percent for localized disease,
73 percent for regional disease, and 28 percent for distant disease. In 2007, 980 women 
in Florida died of ovarian cancer.30 
THOSE AT RISK
Modifiable risk factors that decrease a woman’s risk of ovarian cancer include use of oral 
contraceptives and having children prior to the age of 30. The longer you use oral 
contraceptives, the lower your risk might be. The decrease in risk may last up to 25
years after the use of oral contraceptives has ended. Women who have undergone
tubal ligation (sterilization) are at decreased risk of developing ovarian cancer.
There are many non-modifiable risk factors that increase a woman’s risk of ovarian 
cancer including being over age 55, having a family history of ovarian cancer, having 
had previous breast, endometrial, or colon cancer, carrying the BRCA1 or BRAC2 genes,
and being of Ashkenazi (Eastern European) Jewish descent. Hormone replacement
therapy is associated with an increased risk of ovarian cancer in postmenopausal
women.
“The experience helped me
to understand the importance 
of communication between 
doctors and patients.”
Anonymous, breast cancer survivor.
29 Surveillance Epidemiology and End Results (SEER) Stat Ovarian Cancer Fact Sheet.
Retrieved from http://seer.cancer.gov/statfacts/html/ovary.html.
30 Florida Community Health Assessment Resource Tool Set (CHARTS). Retrieved from
http://www.floridacharts.com/charts/DeathQuery.aspx. 42
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Ovarian Cancer, 1987 - 2006
Rates per 100,000
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CANCER BURDEN 
Source of data: Florida Cancer Data System 
Incidences and mortality rates of ovarian cancer are similar between  Florida and the 
nation. 
Source of data: Florida Cancer Data System 
The lower percentages of early stage ovarian diagnosis from 2001 forward represent a 
change in stage coding, not a true change underlying the disease. 
DISPARITIES 
The incidence rate of ovarian cancer was 37 percent higher among whites than among 
blacks in 2006. 
Since 1981, ovarian cancer mortality rates have decreased by 28 percent among black 
females and by 17 percent among white  females.  The mortality rate among white 
females was 28 percent higher than that of black females in 2006. 
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BEHAVIORAL MEASURES
There are no specific behaviors that reduce the risk for ovarian cancer. However, 
incorporating healthy nutrition and physical activity are important in maintaining one’s
health. Women should be informed of the risks and symptoms by their doctor about
personal and family medical history that may put them at risk for ovarian cancer.
PREVENTION AND EARLY DETECTION
Primary prevention may not be possible, but avoiding modifiable risk factors will 
decrease a woman’s risk of getting ovarian cancer.
Early detection and diagnosis of ovarian cancer is possible though symptom recognition
and regular pelvic examinations, preferably performed by a gynecologist. The USPSTF
recommends against routinely providing CA 125 screening to patients without 
symptoms.
FLORIDA OVARIAN CANCER STRATEGIES
1. Raise awareness of health professionals on the signs and symptoms of ovarian 
cancer.
2. Promote and raise awareness of genetic links and testing options.
3. Increase awareness among Florida women about	 ovarian cancer and its signs 
and symptoms.
4. Promote clinical trial participation.
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PROSTATE CANCER
September is Prostate Cancer Awareness Month
Lifetime Risk of Developing Prostate Cancer is 1 in 6 Men31 
OVERVIEW
Prostate cancer is the most commonly diagnosed cancer and the second leading cause of 
cancer death in men. In Florida, 14,043 new cancer cases and 2,079 cancer deaths were 
related to prostate cancer in 2006.32 
For patients whose tumors are diagnosed at the localized-regional stage, they have a
100 percent five-year relative survival rate after surgery or external beam radiation
therapy. Those diagnosed with advanced or metastatic stages have a 31 percent five-
year survival rate.
The national prostate cancer five-year survival rate for men is 100 percent for localized
disease, 100 percent for regional disease, and 31 percent for distant disease. In 2007,
2,153 men in Florida died of prostate cancer.33 
THOSE AT RISK
Factors that may increase the risk of developing prostate cancer include:
• Age – As a man ages, his risk to be diagnosed with prostate cancer increases.
The average age of patients at the time of diagnosis is 65.
• Family history of prostate cancer – A man’s risk is higher if his father or 
brother had prostate cancer. Relative risk increases with higher numbers of
affected family members, their degree of relatedness, and the age at which 
they were affected.
• Race – The disease is more common in black men than in white men, including
Hispanic white men. It is less common in Asian and American Indian men.
• Diet and dietary factors – Some studies suggest that men who eat a diet high 
in animal fat may be at an increased risk for prostate cancer.
In the US, African American men have the highest
incidence rate for prostate cancer and are more 
than twice as likely as White men to die of the
disease. White women have the highest incidence 
rate for breast cancer, although African American
women are most likely to die from the disease.
(National Cancer Institute)
31 Surveillance Epidemiology and End Results (SEER) Stat Prostate Cancer Fact Sheet. Retrieved from
http://seer.cancer.gov/statfacts/html/prost.html.
32 Florida Cancer Data System Retrieved from http://fcds.med.miami.edu/.
33 Florida Community Health Assessment Resource Tool Set (CHARTS). Retrieved from
http://www.floridacharts.com/charts/DeathQuery.aspx. 45
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CANCER BURDEN
Florida’s 2006 mortality rate for prostate cancer of 18.9 meets the Healthy People 2010
target of 28.8 deaths per 100,000 men.
Florida’s 2006 overall mortality rate for prostate cancer of 18.9 per 100,000 meets the
Healthy People 2010 target of 28.8 deaths per 100,000 men. However, when stratifying
by race/ethnicity, black men is the only racial/ethnic group that has not met the Healthy
People 2010 goal for the nation relating to prostate cancer. In 2006, the reported
mortality rate for prostate cancer in Florida was 17 per 100,000 for white men and 48 
per 100,000 for black men.34 
Source of data: Florida Cancer Data System 
While prostate cancer detection rates in Florida are slightly lower than in the nation  as a 
whole, the mortality rates are nearly identical.   The introduction of Prostate Specific 
Antigen (PSA) testing may explain the “spike” in prostate cancer rates in the early 
1990s. Since the introduction of PSA testing, the incidence of local regional  disease has 
increased, whereas the incidence of advanced or metastatic disease has decreased. 
Source of data: Florida Cancer Data System Source: CDC BRFSS Interactive  website 
34 Florida Cancer Data System Retrieved from http://fcds.med.miami.edu/.
  
 
 
             
            
       
 
 
 
 
              
                 
            
             
            
   
 
            
              
           
              
           
           
             
          
              
           
            
 
            
          
             
              
 
  
 
 
            
           
              
           
 
   
 
           
            
            
           
 
 
          
        
             
           
            
               
                
The percentage of prostate cancer cases diagnosed in an early stage in Florida has
increased by 52 percent in the past 20 years. Reported screening rates are slightly
higher among Floridians compared to the nation.
DISPARITIES
Although death rates for prostate cancer have been on the decline for black and white 
men, rates in black men remain nearly three times as high as rates in white men. While 
incidence rates have become stable in men 65 and older, overall incidence rates remain 
significantly higher in black men than in white men. The reason for this higher 
incidence is unclear, but may be reflective of genetic predispositions, lifestyle, diets, or 
access to care.
While the incidence and mortality rates for all cancers combined have decreased more 
among African American men than for any other racial or ethnic group between 1994­
2003, survival data from the SEER registry (1988-2002), stratified by race and ethnicity
and adjusted by age and stage at diagnosis, show poorer survival for African Americans
(compared with white and Hispanic) males with prostate cancer. Recent findings
indicate the same problems minorities and the medically underserved face while gaining 
access to cancer prevention and screening programs at the initial diagnosis (i.e. access to 
healthcare, insurance coverage, lack of knowledge, awareness, mistrust, lack of cultural
appropriateness, health literacy) remain for those who survive their cancer. Thus, it has
been recommended as an important priority to increase the number of community-
based survivor programs directed to racial and ethnic minorities and the poor.
In a recent review of the literature examining cancer survivorship outcomes (physiologic,
psychosocial), health services and quality of care, and health-promoting behaviors and 
lifestyles, show there is a lack of available evidence for how survivors from racial and 
ethnic groups fare in these areas. Better surveillance systems are needed in these areas.
BEHAVIORAL MEASURES
There are no specific behaviors that reduce the risk for prostate cancer. However, 
incorporating healthy nutrition and physical activity are important in maintaining one’s
health. Men should be informed by their doctor about personal and family medical
history that may put them at higher risk for prostate cancer.
PREVENTION AND EARLY DETECTION
The PSA blood test and Digital Rectal Examination (DRE) are the primary screening tools 
used to detect prostate cancer. Among researchers and clinicians, there has been a 
persistent concern relative to the sensitivity, specificity, and positive predictive value of
prostate cancer screening and early detection modalities currently recommended for 
use.
In response, national institutes, medical organizations, and cancer societies, all have 
formulated position statements, recommendations, and/or guidelines for prostate 
cancer screening. This listing is inclusive of the USPSTF, the American Medical
Association, the American Cancer Society, the American College of Preventive Medicine,
the American College of Physicians, the American College of Radiology, the American
Society of Internal Medicine, and the American Urological Association. While they all
acknowledge the importance of early detection to prostate cancer control, they vary in 47 
  
 
 
 
             
           
       
 
            
              
           
          
     
 
    
 
 
       
 
          
     
            
         
 
          
          
           
          
    
     
        
        
           
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
support of the prostate cancer screening procedures, in the election of prostate cancer
screening schedule, and in their support of a specific prostate cancer screening
guideline (AHRQ Screening Guidelines Appendix F).
Although the value of PSA screening remains controversial, men who present for 
periodic health examinations should be made aware of the availability of PSA testing so 
that they can make informed decisions about their individual need for routine 
screening. Discussion should include the implications for treatment versus continued
monitoring, if positive values are found.
FLORIDA PROSTATE CANCER STRATEGIES
1. Disseminate appropriate prostate cancer education targeted to disparate 
population.
2. Support high quality prostate cancer research and the development of
collaborative research networks across Florida.
3. Increase outreach	 efforts to minority men to educate on prostate cancer risk 
reduction behaviors and informed decision making on prostate cancer
screening.
4. Increase healthcare provider	 utilization of the informed decision making
process to address screening and treatment options for prostate cancer.
5. Increase health	 communication and health education efforts to education the 
public, policy makers, and the healthcare sector about the major issues 
relating to prostate cancer.
6. Raise awareness of survivorship needs.
7. Increase healthcare professionals’	 knowledge, skills, and practice to address
prostate cancer prevention, diagnosis, treatment, rehabilitation, and support
for prostate cancer, as well as improve access and appropriate utilization of 
high quality prostate cancer care.
48
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Appendix A
SYSTEM DYNAMICS MODELING
The Comprehensive Cancer Control (CCC) Program staff hired a consultant with an 
expertise on System Dynamic Thinking/Modeling (SDM) to focus on implementing
systems thinking approaches with strategic planning efforts.  Ultimately, the intent was
to create readiness for the CCC Program to develop an evidence-based system dynamics
support tool that will monitor and assess the performance of planning efforts.
The work was conducted over several phases beginning with interviewing CCC Program
staff, identifying key components of the program, developing a work plan that outlines
the scope and activities in creating a systems dynamics modeling tool specific to the CCC 
Program’s work and the strategic opportunities. The next phase required convening a 
design team and providing the necessary training on the core competencies of system
dynamics modeling. The final phase was providing training to the Florida Cancer Plan 
Council (FCPC) and submitting a final report to the CCC Program with recommendations.
RECOMMENDATIONS:
1. The first step is always internal staff dialogue. What do we have energy and 
resources for and what would an effort look like that included SDM as part of
the process? How are decisions currently made about resource allocation with
your partners and what evidence-base would be helpful to inform their
decision-making?
2. Next, it may be helpful to engage others in the Bureau of Chronic Disease
Prevention and Health Promotion who are struggling with similar issues.
Questions might include:
• How are decisions currently being made in the bureau?
• What are the commonalities with our chronic disease target audiences
and risk factors that might benefit from systems thinking approaches?
• What drives health disparities in Florida and what common actions or 
interventions would require and integrated effort?
3. Engaging	 FCPC members with these recommendations is also important since
many of members were involved in the second workshop. It would be 
important to prepare beforehand and provide the members with the
necessary resources to think critically about the desired outcomes and the role
SDM could play in making better informed decisions.
4. Lastly, consider working within a region to identify and develop the resources
necessary to create effective decision-support tools (i.e. system dynamics
models) for the region. Undoubtedly, the models developed for each cancer
would have benefits for all states struggling with similar disease burdens.
50
  
 
 
  
 
 
  
 
        
 
 
          
            
           
 
 
           
        
 
 
      
  
         
        
  
           
      
         
      
 
 
 
 
           
         
              
               
   
 
        
       
 
        
            
    
 
           
         
     
 
          
          
 
          
           
        
 
 
Appendix B
COMMISSION ON CANCER
A Program Of The American College Of Surgeons
MISSION
The Commission on Cancer (CoC) is a consortium of professional organizations dedicated 
to improving survival and quality of life for cancer patients through standard-setting, 
prevention, research, education, and the monitoring of comprehensive quality care.
HISTORY
Established by the American College of Surgeons (ACoS) in 1922, the multidisciplinary
CoC performs the following activities in healthcare settings:
1. Establish standards to ensure quality, 	multidisciplinary, and comprehensive 

cancer care delivery.
 
2. Conduct surveys to assess compliance with those standards.
3. Collect standardized data from	 CoC-approved health care settings to measure 

cancer care quality.
 
4. Use data to monitor treatment patterns and outcomes and enhance cancer
 
control and clinical surveillance activities.
 
5. Develop effective	 educational interventions to improve cancer prevention,
 
early detection, cancer care delivery and outcomes.
 
MEMBERSHIP
Multidisciplinary membership is comprised of 97 individuals who are either surgeons
representing the ACOS or representatives from the 42 national, professional
organizations affiliated with the CoC. These individuals each participate in one of the 
standing committees or in one of the 13 Disease Site Teams that work to pursue the 
CoC's goals by:
• Establishing standards for 1,433 CoC-approved cancer programs and evaluating 
and accrediting programs according to those standards.
• Overseeing a nationwide network of more than 1,600 physician-volunteers
 
who provide state and local support for CoC and American Cancer Society
 
cancer control initiatives.
 
• Providing oversight and coordination for educational programs of the CoC,
 
which are geared towards surgeons, physicians, cancer registrars, cancer
 
program administrators, and others.
 
• Providing clinical oversight and expertise for CoC standard-setting activities
and for the development, review, and dissemination of patient care guidelines.
• Overseeing and coordinating national site-specific studies of patterns of care 

and outcomes of patient management through the annual collection, analysis,
 
and dissemination of data for all cancer sites.
 
51
  
 
 
  
 
 
          
            
           
           
             
            
               
            
      
 
  
 
 
           
             
          
             
         
          
           
          
              
 
  
 
 
            
          
           
            
           
         
      
 
            
         
 
           
            
             
          
          
              
           
 
            
 
 
           
 
 
              
 
 
IMPACT IN FLORIDA
In 2008, approximately 70 hospital cancer programs in Florida had received CoC 
approval. The location of each CoC-approved program and the services they provided
can be accessed by Floridians using the American Cancer Society's Hospital Locator 
Service at www.cancer.org. Cancer Liaison Physicians at each hospital serve as
community liaisons between their cancer program and the CoC. Each approved hospital
performs one or more quality improvement studies annually at its institution and 
submits its cancer registry data to the National Cancer Database. Annual state meetings
for Cancer Liaison Physicians are held to provide regular updates to community
physicians on CoC initiatives and activities.
QUALITY INITIATIVES
All CoC-approved hospital cancer programs submit their cancer registry data to the 
National Cancer Database, the largest prospective cancer database in existence. This
information is analyzed and reported back to participating hospitals, allowing for 
quality assessment at the local level. The ongoing CoC Electronic Quality Improvement
Project for 2008-2009 includes evaluating the use of adjuvant (supplementary) 
chemotherapy in surgically resected advanced colon cancer, the use of radiation, 
hormonal therapy, and chemotherapy in breast cancer, and proper lymph node
assessment in surgically resected colon cancer. Cancer programs receive regular updated 
reports on their adherence to these national guidelines to promote quality patient care.
FUTURE GOALS
The CoC works to continually update its standards to meet the demands of
contemporary, evolving cancer care. Recent advances include changes to reporting 
requirements for cancer staging to ensure accurate data submission on the National 
Cancer Database and the use of cancer staging and national care guidelines in
treatment planning for cancer patients. Ongoing efforts in electronic reporting will 
ultimately provide real-time, immediate feedback to cancer programs to ensure 
adherence to accepted guidelines of care.
All hospital cancer programs in Florida are encouraged to seek CoC approval, ensuring 
quality cancer care for patients close to their home.
The evaluation should focus on issues of greatest concern to stakeholders, while
efficiently using time and resources. A written plan that summarizes evaluation goals
and procedures and outlines the stakeholders’ roles and responsibilities is essential. The 
plan should include evaluation questions and practical methods for sampling, data 
collection, data analysis, and interpretation. Stakeholders can help prioritize the 
questions to determine which are critical, are likely to improve the partnership, and can
be answered with available resources. Questions may include the following:
• What should the partnership accomplish and how will it be demonstrated?
• What activities will the partnership undertake to accomplish its goals?
• What factors might help or hinder the accomplishment of its goals?
52
  
 
 
 
          
 
 
      
 
 
       
 
 
              
             
            
              
            
           
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Who are the partners (number, diversity, and participation levels)?
• How do partners work together?
• What partnership outcomes should be measured?
The evaluation design is linked to the priority questions, and the choice of design has
implications for what data will be collected and how. A pre-post-test design uses a 
comparison group to measure the partnership on given parameters before and after it 
implements planned improvement strategies, or both. A case study design is used to 
study the partnership’s context, history, structure, and function. Case studies usually rely
on multiple sources of information such as observations, interviews, audiovisual
material, documents, and reports.
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Appendix C
CANCER PARTNERS
We wish to acknowledge the following dedicated organizations who, over the years,
have worked with the DOH to reduce the cancer burden for Floridians.
American Cancer Society 
American College of Surgeons 
Barry University 
Cancer Control and Research Advisory Council (CCRAB) 
C-Change 
Centers for Disease Control and Prevention (CDC) 
Florida Agency for Healthcare Administration 
Florida Agricultural and Mechanical University 
Florida Association of Pediatric Tumor Programs 
Florida Cancer Data System 
Florida Chapter of American Society of Oncology 
Florida Dental Association 
Florida Department of Education 
Florida Department of Health programs and county health departments 
Florida House of Representatives 
Florida Medical Association 
Florida Nurses Association 
Florida Obstetric and Gynecologic Society 
Florida Osteopathic Association 
Florida Pediatric Society Florida 
Pharmacy Association Florida 
Public Health Foundation Florida 
Senate 
Florida Society of Clinical Oncology 
Florida Society of Pathologists 
Florida Tumor Registrars 
General Public Consumer Advocate 
H. Lee Moffitt Cancer Center & Research Institute 
Jackson Memorial Hospital 
Leukemia and Lymphoma Society 
M.D. Anderson Cancer Orlando 
Mayo Clinic 
National  Association of Chronic Disease Directors 
National  Association of Consumer Advocates 
National Cancer Institute/Cancer  Information Service 
National  Ovarian Cancer Coalition 
Northeast Florida Cancer Collaborative 
Northwest Florida Cancer Collaborative 
Nova Southeastern College of Osteopathic Medicine 
Nova Southeastern University 
Oncology Nursing Society 
Ovarian Cancer National  Alliance 
Continued on next page54
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
University of Miami Sylvester Comprehensive Cancer Center 
University of Florida 
University of Florida/CDC Right to Know 
University of Florida College of Medicine 
University of Miami School of Medicine 
University of South Florida Public Health 
55
Shands Hospital 
Southeast Florida Cancer Collaborative 
Southwest Florida Cancer Collaborative 
St. Petersburg College 
Susan G. Komen Foundation for the Cure 
Tallahassee Memorial Hospital 
  
 
 
  
 
 
          
 
 
              
           
             
             
             
           
           
        
 
          
            
            
      
 
            
           
            
         
              
  
 
           
            
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix D
FLORIDA CANCER PLAN 2010 GUIDE: Building Blocks to Reduce the Burden
The Florida Cancer Plan Guide: Building Blocks to Reduce the Burden is to be used in
tandem with the Florida Cancer Plan.  The Florida Cancer Plan provides the “large
picture” of planning with general strategies defined. The Florida Cancer Plan Guide 
serves as a working document, which grows off the Florida Cancer Plan and allows each 
stakeholder group to use the general strategies to create a vision for their specific 
planning activities. Both documents were created through collaborative efforts of
members of the Florida Cancer Control and Research Advisory Council, the Florida 
Cancer Plan Council, and the Florida Department of Health.
The Center for Disease Control and Prevention created the Guidance for Comprehensive 
Cancer Control Planning Volume 2: Toolkit as a resource for the national comprehensive 
cancer control programs. This toolkit was based upon the collective expertise and 
insight from six model planning states.
The CDC toolkit was instrumental in the framework for developing the Florida Cancer
Plan Guide. Based on the toolkit, the Florida Cancer Plan Guide incorporated six 
important areas of comprehensive cancer control - the “building blocks” for planning 
and implementation. The Florida Cancer Plan Guide uses the “building blocks” to 
provide guidance for stakeholder groups to map out their cancer control activities and 
identifying outcomes.
Initially, a stakeholder group will review and incorporate the building blocks for 
comprehensive cancer control planning to guide them in the developing their local 
collaborative and to focus their cancer control efforts.
56
  
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              
             
          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
   
 
   
 
 
BUILDING BLOCKS OF COMPREHENSIVE CANCER CONTROL PLANNING
Bu ild Partnerships 
Assess & Address the Cancer Burden
Conduct Evaluation 
Next, the stakeholder group can utilize the Florida Cancer Plan Guide to provide
guidance on the next steps in implementing cancer control activities in cooperation with 
the building blocks of comprehensive cancer control for implementation.
“Whether I wanted to believe 
it or not, my surgeon 
confirmed it with three words, 
"YOU HAVE CANCER."
Pamela Burnett, cancer survivor.
Enhance Infrastructure 
Mobilize Support 
Utilize Data and Research 
57
  
 
 
            
              
              
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Organize a Plan of Action 
Obtain Implementation Resources
Get Widespread Support 
Track Implementation Progress 
58
The Florida Cancer Plan Guide includes a tool to assist stakeholder groups in succinctly
recording their prioritized cancer control activities, in an action plan format. The action
plan template (See next page) outlines a step by step process to achieve the prioritized
goal.
BUILDING BLOCKS OF COMPREHENSIVE CANCER CONTROL IMPLEMENTATION
Select a Priority 
Assemble a Team with a Leader 
TEACTION PLAN TEMPLA
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Terminology
Abnormal results for breast and cervical cancer exams require that additional exams
need to be done promptly to determine if an abnormal condition exists. Up to 20 
percent of exams need further studies. Only 1-2 percent of these further studies will 
have results that indicate cancer.
Biopsy: Removal of cells or tissue for an examination by a pathologist to determine
whether disease is present. The three most common biopsies are 1) incisional biopsy, in
which only a sample is removed 2) excisional biopsy, in which an entire lump or 
suspicious area is removed, and 3) needle biopsy, in which a sample of tissue or fluid is
removed with a needle. When a wide needle is used to remove tissue, the samples are
called core biopsies. When a thin needle is used and fluid removed, the procedure is
called a fine needle aspiration.
Breast Cancer: Malignant tissue growth in the breast, which is usually in the ducts or 
lobules.
Cancer: A term for diseases in which abnormal cells divide without control. Cancer cells
can invade and can spread to other parts of the body through the blood and lymph 
systems. There are several main types of cancer.
Cancer screening: Checking for changes in tissue, cells, or fluids that may indicate the 
possibility of cancer when there are no symptoms.
Colonoscopy: An examination of the rectum and entire colon using a lighted instrument
called a colonoscope. A colonoscope allows the physician to remove polyps or other
abnormal tissue for examination under a microscope.
Cervical Cancer: Malignant tissues of the cervix (the organ connecting the uterus and 
vagina).
Clinical breast exam: A breast exam preformed by a healthcare provider.
Colposcopy: The examination of vaginal and cervical tissues by means of a colposcope 
which is a magnifying lens. Colposcopy is used to select sites of abnormal cells for biopsy
in patients with abnormal Pap tests.
Diagnostic Procedures: Exams used to diagnose disease or health status.
Digital mammogram: A technique that uses a computer rather than an x-ray film to 
record x-ray images of the breast.
Digital rectal exam (DRE): A test in which the healthcare provider inserts a lubricated,
gloved finger into the rectum to feel for abnormal areas.
Fecal Occult Blood Test (FOBT): A test to check for blood in the stool. Small samples of
stool are placed on a special card and sent to a doctor or laboratory for testing. Blood in
the stool may be a sign of colorectal cancer.
60
  
 
 
  
 
 
            
           
 
                 
               
       
 
               
 
 
             
             
 
 
          
 
 
            
             
              
        
 
             
           
 
                 
 
               
   
            
       
              
   
             
   
 
             
 
 
               
       
 
          
            
              
         
 
 
 
 
 
 
 
 
 
Malignant: Cancerous.
Normal results for breast and cervical cancer exams require no immediate follow-up.
You return to regular screening schedules as determined by your provider.
Pap Test: A screening test to find cell changes in the cervix. Cells are collected from
the cervix. When abnormal cells are identified, the patient will need follow-up testing
such as repeat Pap screening or colposcopy.
Pre cancerous: A term for a growth that is not yet, but may become, cancerous.
Prostate-specific antigen test (PSA): A test that measures the level of an enzyme (PSA)
in the blood that increases due to diseases of the prostate gland, including prostate 
cancer.
Risk factor: Something that increases a person’s chance of developing a disease.
Sigmoidoscopy: A procedure in which the physician or healthcare provider looks 
inside the rectum and the lower part of the colon (sigmoid colon) through a flexible 
lighted tube. During the procedure, the physician or healthcare provider may collect
samples of tissues or cells for closer examination.
Stage: The size and extent of a cancer, including whether the disease has spread from
the original site into surrounding tissue and other parts of the body.
• In situ - early cancer that is present only in the layer of cells in which it 
began.
• Localized - cancer that is limited to the organ in which it began, without
evidence of spread.
• Regional - cancer that has spread beyond the original (primary) site to 
nearby lymph nodes or organs and tissues.
• Distant - cancer that has spread from the primary site to distant organs or 
distant lymph nodes.
• Unknown - used to describe cases for which there is not enough information 
to indicate a stage.
Screenings: Exams to find abnormal tissue at the earliest most treatable stages.
Screening Mammogram: An x-ray of the breast taken to check for breast cancer that
can detect cancer before a lump is felt.
Ultrasound: A procedure in which high-energy frequency sound waves are bounced
off internal tissue or organs and make echoes. The echo patterns are shown on the 
screen of an ultra sound machine. Breast ultrasound may be used to see whether a 
lump is solid or filled with fluid.
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Appendix F
Agency for Healthcare Research and Quality Screening Guidelines 
U.S. Preventive Services Task Force Screening Guidelines 
The U.S. Preventive Services Task Force (USPSTF) was convened by the Public Health 
Service to rigorously evaluate clinical research in order to assess the merits of
preventive measures, including screening tests, counseling, immunizations, and 
preventive medications.
Men’s Cancer Screenings
CANCER SCREENING METHOD AGE TO START TIME FRAME 
Colon/rectum 
Colon/rectum 
fecal occult blood test (FOBT) 
colonoscopy
50 
50 
yearly 
every 10 years 
Colon/rectum sigmoidoscopy 50 every 5 years 
Prostate gland digital rectal exam 50 discuss with your doctor 
Prostate gland PSA blood test 50 discuss with your doctor 
Skin full-body skin exam discuss with your doctor discuss with your doctor 
Women’s Cancer Screenings 
CANCER SCREENING METHOD AGE TO START TIME FRAME 
Breast mammogram 50 every 2 years 
Cervix Pap test 21 discuss with your doctor
Colon/rectum 
Colon/rectum
fecal occult bloot test (FOBT) 
colonoscopy
50 
50
yearly 
every 10 years
Colon/rectum sigmoidoscopy 50 every 5 years
Skin full-body skin exam discuss with your doctor discuss with your doctor 
The guidelines provided are for informational purposes only.  To determine  which screenings are appropriate 
for you, please consult your healthcare professional. 
For additional information visit the Agency for Healthcare Research and Quality’s
website at: http://www.ahrq.gov/clinic/cps3dix.htm#cancer.
  
 
 
  
  
             
          
             
            
             
        
        
             
              
                   
           
                 
             
              
 
 
              
           
           
           
             
             
            
             
             
              
          
 
 
 
  
 
              
                 
             
              
           
            
            
             
            
                   
            
           
     
 
Appendix G 
My Cancer Story 
STORY 1:
“On October 9, 2003 my life was changed forever as I heard the words from the
physician “The tests show that you have Multiple Myeloma.” Momentarily, I became
numb and speechless. Sometimes challenges in life can seem very surreal. I have worked
17 years as a Licensed Clinical Social Worker on the Bone Marrow Transplant Unit at 
Shands Hospital at the University of Florida. As the BMTU social worker, I complete pre-
transplant psychosocial evaluations, provide counseling, crisis intervention, referrals to 
community resources, facilitate the BMTU Patient/Family Support Group. Although work 
experience had given me some knowledge of this disease and the treatment process, my 
challenge now was not to intellectualize this or look for the outside in. Neither was
denial an option. I had to face it head on. I had to accept it, cope with it and more
importantly survive it. I educated myself about the disease and its treatments, pulled 
from my inner strength used to cope with previous crises, relied on my spiritual faith,
asked others for help, accepted support from others and to this very day, remain
hopeful that someday there will be a cure. This October will be 6 years since I was first 
diagnosed.
My journey as a cancer advocate, educator, and facilitator did not start nor does it end 
with my employment. I have volunteered in the community and several cancer
organizations for more than 15 years. I am a Co- Regional Coordinator for the Florida 
Society of Oncology Social Workers, a member of the Shands Hospital Cancer
Committee, a volunteer and member on the local board of the American Cancer Society
and volunteer for the Leukemia & Lymphoma Society. My volunteer work and advocacy
has afforded me many opportunities to enhance my knowledge and skills and more
importantly, to help others cope with life’s adversities. June 3, 2007, I completed the half
marathon at the “Rock-n-Roll” Marathon in San Diego. I am grateful for the support
and assistance from all of the people throughout this State and Country who make a 
difference in the lives of all cancer survivors, families and caregivers.
STORY 2:
“Melanoma – While I had worked with melanoma for years I was surprised to be told 
that I had it on my left ear. And later I was more surprised when it recurred after the
original melanoma was removed. This led to complete removal of my left ear, a skin
graft, and local radiation treatment at the Moffitt unit at Tampa General Hospital. All of
this would not have been possible without many clinical research reports on the 
treatment of melanoma which continues to evolve. Based on the extent of the 
melanoma in my recurrence I received treatment with Interferon which was determined
on the basis of numerous clinical trials. When I discussed changes to the care with my 
practitioner at Moffitt, he kindly reminded me that variation in my treatment would 
create a series of one – that is me. This response kept me with the program which for
me is periodic follow-up to check for recurrences. However, I know I would not be here 
today without the foundation of medical research and the care that I have received
from a number of dedicated professionals.” 
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STORY 3:
“Miss Florida Teen USA Kayla Collier was 15 when she first visited a tanning salon so the 

stage lights at a local pageant wouldn't make her fair skin look ghostly white.
 
Later that year, as she tried on homecoming dresses, her mother noticed what looked like a 

scab on her back. It turned out to be skin cancer.
 
And though she can't definitively link the tanning to the cancer, Collier, now 18 and 

healthy, won't be back under the bulbs. Last week, her voice catching, she asked Sunshine 

State lawmakers to ban people under 16 from using tanning beds.”
 
STORY 4:
“I have worked in the field of cancer for over 20 years, got mammograms, and did what I 
thought were the right things to prevent cancer. When a routine mammogram showed 
something suspicious seven years ago, my first thought was, “I can’t get cancer – I work in
the field! I should be exempt!” But, that’s not the way things go. After looking into my 
options and getting several opinions, I had a lumpectomy, radiation therapy, and hormone
therapy. Because I was treated where I work, going to appointments seemed like going to 
meetings! I guess I was somewhat detached and thought of my treatment as a way of
learning about cancer treatment from the perspective of a patient, and checking out how
much information is given to patients. I hope I wasn’t a typical patient because I don’t 
remember receiving a lot of information. At the time, I wondered if that was because I 
worked in the field. But maybe I did get information but blocked it out at the time, like
many people do when they are overwhelmed with making medical decisions. The 
experience helped me to understand the importance of communications between doctors
and patients, and to realize that health care professionals should not assume patients have 
all the information they need. Having seen cancer from many sides – as a professional, a 
patient, and a family member of people with cancer - I'm glad that there are so many
caring and concerned professionals available to help. I hope that the Florida Cancer Plan 
will serve as a guide for agencies and individuals to continue to work toward reduce the 
burden of cancer in our state.”
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Anonymous
STORY 5:
“Millions of people are diagnosed with cancer every year, but not me; so I thought.
Then in the month of November 2002, I was told I was one in that million.
For eighteen months I was misdiagnosed and told that I had fatty tissue, when in fact I 
had breast cancer. This diagnosis of breast cancer left me stunned and speechless. "This
is just not true," I told myself. I did not believe what I just heard. Whether I wanted to 
believe it or not, my surgeon confirmed it with three words, "YOU HAVE CANCER." I 
screamed!
After numerous operations, radiation treatments, staph infection and a failed breast
implant brought on new illnesses such as diabetes, hypertension, bleeding ulcers, and
the worst of it, DEPRESSION. I attempted a "foolish act," which could have cost me my 
life. Instead of acting on it, I sought professional help, which was the BEST decision I 
ever made. This became a part of my recovery process which led me to assist others who 
were diagnosed with cancer.
In 2004, the opening of a cancer support center was weighing heavily on my heart. I 
wanted to provide a place for cancer patients and their families to come and discuss 
their problems or issues; a place to voice their frustrations; a place to have their needs
met so that the stress in their lives, caused by their illness, can be alleviated. I felt that
without this type of interpersonal support they could lose all hope and feel they have 
no one to turn to during their health, spiritual or financial strains. I wanted them to 
know that they can trust me, because I am one of them...A SURVIVOR who did not give 
up HOPE or faith; a battle that was won by the grace and mercy of God. In 2006, after
reading the Book of Acts from the bible the birth of The Beautiful Gate Cancer Resource 
Center was born with the mission to provide all who enter through the gate with the 
support they need.”
STORY 6:
A Florida cervical cancer survivor and participant in the Florida Breast and Cervical 
Cancer Early Detection Program reported that her participation in the program was the 
kindest thing that has ever happened to her family. She said everyone was so caring 
and she hopes that no woman is ever afraid to come in and get the help they need.
“I had to face it head on. I
had to accept it, cope with
it and more importantly
survive it.”
Gale Smith, cancer survivor. 65 
  
 
 
 
  
 
 
              
               
            
               
            
                 
             
        
 
              
           
         
              
                
           
        
 
  
 
 
   
 
 
               
              
            
              
               
         
 
              
          
              
            
               
            
     
 
            
               
 
Anonymous
STORY 7:
“Terrified, scared, and shocked. My body shook uncontrollably. I gathered  all my 
strength to explain to my daughters that I was not going to die. I was ready to fight for 
my life. I met with  the oncology team, underwent CT scans and MRI screenings, and 
resigned from work. The plan was to receive neo-adjuvant chemotherapy followed by a 
bilateral mastectomy with  complete lymph node dissection. I prayed for the strength  to 
endure the treatment. I prepared my daughters for worst case scenarios. But I promised 
them, as well as family and close friends, that this was a challenge I had to face and 
overcome. My faith  was my source of strength;  my family was my motivation not to give 
up. 
The night before my first chemo was an emotional struggle. I was taking medication that
would reduce the side effects of a drug that would kill all the cells in my body. My 
husband’s words changed my perspective. He said that the chemo was going to kill what
it needed to in order to save my life. The side effects included loss of appetite, fatigue,
and soreness. My count was one down, five to go. The side effects increased, but each 
chemo visit was one closer to the last one. I had time to reflect on the privilege to fight
for my life. While I was self absorbed and consumed by my situation, I was determined to 
demonstrate a positive attitude in how I was handling it.
The surgery to me was the final step in the treatment plan. It was over; it was gone. Each 
today was better than yesterday. The next few months included the tissue expander
exchange for the silicone breast implants, followed by surgery.
I do not want the word “cancer” to define who I am. During this difficult time, I 
completed my doctoral studies. I love life and savor every minute with loved ones. I live
in the present. I have fewer fears. I am a wife, mother, sister, daughter, friend, and 
teacher. Those are the words that define me.”
STORY 8:
Paul A. Pitel, MD
“Like many people, my choice of career in the cancer field was profoundly affected by
my exposure to a specific individual. As a 2nd year medical student at Brown, we had an 
elective on medical ethics taught by the head of Pediatric Hematology-Oncology. I was
fascinated to watch Dr. Ed Forman range across the biology of his practice, to the 
psychology of working with very ill patients and their families, to the ethical questions
raised by research on children. I was starting to be hooked.
The greatest improvements in caring for children with cancer probably fall into a few
broad areas. First, supportive care – antibiotics, hematopoietic stimulants (such as G-CSF),
pain control – are profoundly better. CVAC’s were not yet invented. Second, imaging 
modalities have improved to a revolutionary degree. When I started my practice, CT
scans were rare and poor quality. MRI and PET, among others, simply did not exist. Last,
our understanding of tumor biology, affecting diagnosis and risk assessment, has
changed to an extraordinary degree.
My greatest disappointments, in terms of change in cancer care during my career, fall 
into three broad areas. First, the United States has not yet figured out how to insure
66
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people to receive all the benefits modern medicine can provide. This is even more
profound when it affects children. Second, the “bad diseases” – high risk
neuroblastoma, very high-risk ALL, relapsed disease – are still very difficult to cure. Last, I 
still do not fully understand – and do not accept – the very low levels of adult patient
accrual onto oncology therapeutic protocols. The gap between adult and pediatric
practice remains too great.
A cancer-related program I really enjoy working with is the Florida Division of the 
American Cancer Society in its Reach Out to Cancer Kids (R.O.C.K.) programs. These 
include R.O.C.K. Camp, R.O.C.K. Family Weekends, and the College Scholarship Program.
These are all terrific.”
“I know I would not be here 
today without the foundation 
of medical research and the 
care that I have received”.
John Mason, cancer survivor.
  
 
 
 
  
 
     
 
 
    
            
      
 
        
        
   
 
        
      
       
        
 
   
 
 
          
    
     
 
        
 
 
    
 
ADDITIONAL RESOURCES
Resources for community cancer partners.
For Information About Cancer:
Contact your local health department or healthcare provider for information about
resources and programs in your area.
National Cancer Institute’s toll-free and confidential: 1-800-4-CANCER or 1-800-422-6237 
(Para información en Español) or www.cancer.gov or www.cancer.gov/espanol (Para 
información en Español)
American Cancer Society is toll-free: 1-800-227-2345 or visit www.cancer.org
(http://www.cancer.org/ docroot/ESP/ESP_0.asp para información en español.)
Centers for Disease Control and Prevention: http://www.cdc.gov/cancer/index.htm
Cancer Control Research and Advisory Council (CCRAB): www.moffitt.org
FLORIDA CANCER CONTROL:
Breast and Cervical Cancer Early Detection, Colorectal Cancer Control and the 
Comprehensive Cancer Control Program: 850-245-4330 or 
http://www.floridashealth.com/ or e-mail directly cancer@doh.state.fl.us
Florida Cancer Data System Florida’s cancer registry: http://fcds.med.miami.edu
Tobacco Prevention Program: 850-245-4144 or
DHAT_TobaccoControlProgram@doh.state.fl.us
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